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LARYNGOPHARYNGEAL REFLUX – AN OVERVIEW 
In order to complete digestion, ruminating mammals have a physiological back and forth 
motion in their digestive track, which allows regurgitation of food back to the mouth for 
further chewing and mixing with saliva before the ingesta returns to the stomach.  
In humans, however, the retrograde flow of the stomach contents into the esophagus is a 
non-physiological event attributed to a transiently compliant lower esophageal sphincter. 
Although this retrograde flow can occur up to 50 times a day, especially after meals, with 
no significant consequences as the esophageal mucosa is well prepared to intermittently 
contact with the acidic gastric contents, significant sustained exposure is known to be the 
cause of a chronic pathological condition named Gastroesophageal Reflux Disease 
(GERD). GERD is characterized by classic digestive symptoms such as heartburn and 
acid regurgitation and can lead to complications, e.g. esophagitis, esophageal strictures, 
and Barrett's esophagus. In the Western World it is estimated that between 10 to 20% of 
the population is affected by GERD, and its association to modern lifestyle habits such as 
the ingestion of certain foods (e.g. soft drinks, fatty foods, coffee, chocolate, spicy foods), 
alcohol consumption, smoking, obesity, and use of certain drugs has led some authors to 
consider GERD a modern life hazard.    
Well known to gastroenterologists for decades, it was only in the 1980s that the 
groundbreaking work of Pellegrini and DeMeester, and of the Castell group, including 
Koufman,1 who would later extensively investigate the subject, revealed the importance 
of reflux in airway pathology. Although occasional reports of reflux negatively impacting 
on the respiratory tract date back as earlier as the late 1960s, these authors showed, with 




(with the second pH probe placed in the hypopharynx) –, that the backflow of gastric 
contents in humans can pass the upper esophageal sphincter all the way up to the upper 
aerodigestive tract and produce laryngeal and pharyngeal symptoms.1 Koufman 
demonstrated, in an animal model, that single acid reflux events of short duration 
occurring three days weekly over two weeks were able to cause continuous inflammation 
of the respiratory mucosa.1 This led to the reasoning that it would also take perhaps only 
as little as three reflux episodes per week to equally produce permanent inflammation of 
the respiratory mucosa in human supra-esophageal reflux disease.1 In addition, pH-metry 
studies clearly showed that patients could experience several supra-esophageal reflux 
episodes in a 24-hour period, which, as single events, were usually asymptomatic and not 
identified as heartburn or as an acid regurgitation feeling.1,2 Another major conclusion of 
Koufman’s investigation was that acid-activated pepsin was the primary injurious 
component of the refluxate,1,2 still showing capacity to inflict damage to the respiratory 
mucosa at pH values significantly higher than those in  the stomach.2 Later on it was 
revealed that, in addition to direct peptic-acid injury, vagus-mediated neuroinflammatory 
changes could also contribute to the pathogenic mechanism in supra-esophageal reflux 
disease.2  
Subsequent studies have shown that the pattern of pharyngeal reflux is in many other 
ways different from classic GERD, with events occurring predominantly during daytime 
in the upright position in mostly non-obese subjects; by contrast, GERD is characterized 
by reflux episodes that usually occur in the supine nocturnal position in patients with an 




In order to differentiate GERD from this supra-esophageal reflux disease, which presents 
with a variety of symptoms that gastroenterologists usually disregard such as cough, 
hoarseness, and globus sensation, a new term was coined – Laryngopharyngeal Reflux 
(LPR) – to replace outdated nomenclature such as atypical, occult or silent reflux, reflux 
laryngitis, and supra-esophageal reflux.1,2  Dysfunction of the upper esophageal sphincter 
was suggested as its cause, and emphasis was put on the fact that heartburn and other 
digestive symptoms were absent in more than 50% of the cases (only 1/3 of the GERD 
cases overlap with LPR, and esophagitis is present in only 1/5 of the LPR cases), 
impelling clinicians to look for certain airway symptoms to consider this etiology.2 A 
myriad of laryngeal and pharyngeal complaints have since been attributed to LPR, such 
as postnasal drip, recurrent pharyngitis, difficulty swallowing, globus pharyngis, chronic 
cough, chronic throat-clearing and intermittent hoarseness and other voice 
disturbances.1,2 LPR has also been implicated in the etiology of chronic laryngitis, 
laryngeal carcinoma, subglottic stenosis, laryngeal granulomas, contact ulcers, and vocal 
nodules;1,2  even chronic inflammatory sinus and ear diseases have been linked to LPR.2  
LPR is currently believed to be one of the most important and common causes of 
inflammation in the upper airway, and it is, according to some, still often underdiagnosed 
and undertreated in the clinical setting, even by mindful otolaryngologists.2  
Laryngoscopy is an important, easily performed test that is often employed in the 
diagnosis of LPR, but its results are fairly unspecific – erythema and edema of the 





The gold standard diagnostic tool for LPR, 24-hour esophageal pH monitoring,1,2 is 
simply expensive, not widely available, and too unpractical to use in everyday clinical 
practice, inasmuch the current prevalence of LPR is estimated as having already reached 
epidemic proportions.2 Moreover, dual-probe pH monitoring is still plagued by a lack of 
consensus regarding its methodology and does not provide a clear-cut division between 
those who suffer from LPR and healthy subjects since a number of individuals without 
symptoms also have laryngopharyngeal reflux.2 Undoubtedly more people than it is 
clinically acknowledged have reflux reaching their laryngopharyngeal mucosa, and it is 
currently believed that the ones with symptoms are solely those who have a deficient 
mucosal protection mechanism against refluxate.2 Indeed carbonic anhydrase type III, an 
enzyme that exerts an important epithelial protective function through active secretion of 
bicarbonate, a neutralizer of acid reflux, has been shown to be absent from the laryngeal 
mucosa in most people with LPR.  
Response to acid suppression therapy with twice-daily proton-pump inhibitors (PPIs) is 
currently the most commonly used empiric diagnostic tool to confirm the diagnosis of 
LPR,2 and some clinicians emphasize that symptoms usually improve before the 
laryngoscopic findings resolve. The failure of PPIs to ameliorate symptoms after a long 
enough period of treatment (opinions vary between 1 to 12 months) is unfortunately quite 
common,2 which gives an idea of the complexity of the mechanisms involved. Clinically, 
it may be then necessary to either perform 24-hour pH testing (or test to detect pepsin in 
the hypopharynx) to confirm LPR, or to re-evaluate the initial diagnosis. 
Esophagogastroduodenal endoscopy may be useful to identify nonacid  reflux (duodenal-




those cases prokinetic agents may be a helpful adjuvant and Nissen fundoplication 
surgery may have to be considered.  
Although previous research suggested otherwise, a recent study investigating the 
influence that coexistent Helicobacter pylori gastric infection can have on the success 
rate of LPR treatment with PPIs demonstrated that parallel eradication of the bacterium’s 
gastric infection was able to significantly improve the efficacy of the PPIs in the 
treatment of LPR symptoms.        
On the other hand, behavioral and dietary changes, empirically advocated for GERD 
treatment but lacking real substantive scientific support,2 had their efficacy recently 
reassessed in the treatment of LPR, with some authors currently recommending a non-
acid diet with alkaline water for those patients with LPR who are resistant to PPI therapy.          
 
HELICOBACTER PYLORI – AN OVERVIEW 
H. pylori is a helix-shaped gram-negative bacterium prevalent in the gastric contents of a 
large number of humans worldwide.3 More than 50% of the world's population harbors 
the germ in their stomach, with prevalence rates as high as 80% in developing countries 
and in communities with poor socioeconomic status.3 The infection it causes is 
asymptomatic in over 80% of the cases, and admittedly even plays a role in the natural 
stomach ecology.3 Once infected, usually in early childhood, people will maintain 
lifelong H. pylori colonization until eradication by specific therapy or until gastric 
changes at an old age make the stomach inhospitable to colonization.3  
Transmission is believed to be via the fecal-oral route and also, possibly, the oral-oral 




it manages to survive the extremely acidic pH by rapidly penetrating, through the active 
motion of its four to six flagella, the mucoid layer of the gastric mucosa, and by digging 
deep it attains the surface of the epithelial layer. Here, deep in the mucoid lining of the 
gastric mucosa with a more neutral pH milieu, the bacterium finds its niche in the human 
body, occasionally penetrating the epithelial cells, but mostly adhering to epithelial cells’ 
external surface receptors.3 The non-invasive mucosal surface attachment of the 
bacterium is, nevertheless, highly immunogenic, triggering a specific host response that 
involves neutrophils, T and B lymphocytes, plasma cells, and macrophages.3  
Facing the permanent need of neutralizing gastric acid, H. pylori immediately engages in 
the local production of large amounts of the enzyme urease in order to create a basic 
milieu around itself.3 Host tissue damage occurs when urease breaks down the urea 
normally found in the stomach to produce ammonia, which, together with other products 
of the H. pylori metabolism and potentiated by the acid and pepsin in the gastric lumen, 
has a toxic effect on the epithelial cells.3 The two most well-known products of H. pylori 
metabolism responsible for increasing pathogenicity on the gastric epithelium are 
proteins CagA and VacA, and their production characterizes the more virulent strains of 
H. pylori.3         
Although the infection is expressed clinically in highly variable ways, virtually all H. 
pylori-infected persons have chronic superficial gastritis, often displaying a patchy 
distribution at the stomach mucosal surface.3 The germ’s pathogenic capacity, however, 
depends on the interaction of several factors, including H. pylori strain-specific virulence 
factors (such as CagA and VacA), host susceptibility, environmental factors such as diet, 




the infected individuals not developing clinical disease, there is a lifetime risk of 
developing peptic ulcer disease in 10% to 20%, stomach cancer in 1% to 2%, and  gastric 
MALT lymphoma in less than 1%.3 CagA and VacA production is usually low or absent 
in the H. pylori strains isolated from asymptomatic carriers of the germ, whilst the strains 
of H. pylori that produce high levels of these proteins are generally associated with the 
more pathogenic and symptomatic forms of the infection, including an increased risk of 
developing gastric cancer. 
There is currently a wide consensus that there is no need to diagnose or even treat all 
cases of H. pylori gastric colonization, a virtually impossible task anyway since H. pylori 
gastric infection is the most widespread infection in the world and more than half of the 
world’s population is infected.3 Some authors even argue that H. pylori gastric 
colonization is part of the natural stomach ecology, hence more harm than good will 
likely result from eradicating the germ without necessity. The prolonged systemic 
immunologic response that H. pylori gastric colonization induces seems to benefit a 
number of diseases with an immunological component, henceforth the reported reduced 
prevalence of asthma, rhinitis, dermatitis, and inflammatory bowel disease in patients 
with H. pylori gastric infection.3 Epidemiological studies have also shown that 
populations with higher rates of H. pylori gastric colonization have less severe GERD 
and lower incidence of esophageal adenocarcinoma, lending support to the thesis that H. 
pylori gastric colonization might somehow protect against reflux disease.3 However, H. 
pylori eradication therapy has definitely been proven not to cause or exacerbate reflux 
disease, and the efficacy of PPIs in the treatment of reflux seems not to be altered by the 




gastric infection should not be done routinely but only in specific circumstances: if peptic 
ulcer disease (active or not), atrophic gastritis or MALT lymphoma are present, after 
gastric cancer surgery, on first-degree relatives of patients with gastric cancer, and in 
certain cases of non-ulcer H. pylori positive dyspepsia. Another indication was recently 
added for treatment of H. pylori infection: patients who are on long-term treatment with 
PPIs and simultaneously have H. pylori gastric colonization seem to have a higher risk of 
developing atrophic gastritis, thus prophylactic H. pylori eradication may have to be 
considered in these patients.3        
Invasive and non-invasive tests are used for the diagnosis of H. pylori gastric infection.3 
Non-invasive tests include the urea breath test, stool antigen tests, and serological tests 
(anti-H. pylori IgG, and anti-H. pylori CagA IgG antibodies). H. pylori can also be 
detected by histology, microbial culture, rapid urease test and polymerase chain reaction 
(PCR) tests on biopsied gastric mucosa samples collected during a gastroduodenal 
endoscopy.3   
It has to be acknowledged that the sensitivity and specificity of each test varies (i.e. 
culture of the H. pylori organism from gastric biopsy material has the highest specificity 
but it is the least sensitive diagnostic test, whilst the other tests have a slightly lower 
specificity, but are more sensitive in various degrees) and that, with the exception of the 
serologic tests, false negative results may occur in patients who have taken antibiotics or 
omeprazole in the recent past. Consensual amongst researchers, however, is the fact that 
it is inappropriate to prescribe anti-H. pylori therapy without a firm diagnosis. 
The 14-day “triple therapy”, which includes two antibiotics (clarithromycin and 




as first-line treatment. Although other treatment regimens with different combinations of 
antimicrobials have been proposed, the “standard” triple PPI-clarithromycin and 
amoxicillin or metronidazole therapy is reported as progressively losing efficacy due to 
increasing antimicrobial resistance in certain parts of the world.3      
 
LARYNGOPHARYNGEAL REFLUX, H. PYLORI AND INFLAMMATORY 
DISEASE OF THE UPPER AERODIGESTIVE AND RESPIRATORY TRACT  
 
LPR and Otitis Media  
As soon as it was recognized that LPR could be linked from an etiopathogenic 
perspective to laryngeal and pharyngeal pathology, several reports emerged, 
incriminating LPR in disease processes even higher up in the respiratory tract, such as in 
the nose and sinus and in the middle ear.  
Tasker et al. 4 in 2002 were among the first to report they had found pepsin/pepsinogen 
concentrations levels up to 1000 times higher than serum levels in middle ear fluid from 
children with otitis media with effusion, which led to the conclusion that the gastric juice 
seems to play a role in its etiopathogenesis.  
Since then, other authors repeated the same observation with varying pepsin/pepsinogen 
values.   
Miura et al.5 recently conducted a meta-analysis of the literature on the association 
between otitis media and gastroesophageal reflux, selecting only 15 out of 242 papers as 
suitable for inclusion. From those data they concluded that the reported prevalence of 




is indeed significantly higher than the prevalence of GERD in the general pediatric 
population: the mean prevalence of GERD in children with chronic otitis media with 
effusion is 48.4% (range, 17.6%-64%), and in children with recurrent acute otitis media it 
is 62.9% (range, 61.5%-64.3%). The mean prevalence of LPR in children with otitis 
media is 48.6% (range, 27.3%-70.6%), whereas the mean middle ear pepsin/pepsinogen 
presence in otitis media is 85.3% (range, 60%-100%) and enzymatic activity is 34.2%. 
The authors stress, however, the fact that the two sole randomized studies in the literature 
on the efficacy of PPIs in otitis media treatment could not find a significant benefit.  
     
LPR and Sinusitis1    
Chambers et al. 6 evaluated the predictive objective factors of poor outcomes after 
endoscopic sinus surgery and were somehow surprised to find that GERD, on par with 
the post-operative scarring of the ostio-meatal complex region, was the most critical 
variable.  
Bothwell et al.7 prescribed anti-reflux therapy to 28 children selected for sinus surgery 
due to recalcitrant chronic rhinosinusitis (CRS) and reported that only 3 still required 
surgery at the end of the treatment. They concluded that reflux should always be assessed 
and treated before sinus surgery is considered in children.     
Catalano et al.8 assessed, using gastroesophageal endoscopy, the prevalence of 
esophagitis in 110 adult patients with no digestive symptoms but suffering from various 
upper respiratory tract pathologies (posterior laryngitis, vocal fold nodules and chronic 
sinusitis). In comparison to 117 subjects undergoing gastroesophageal endoscopy for 
                                                 




other reasons than GERD, they found that the patients with those upper airway disorders 
have a significantly higher prevalence of esophagitis than controls (31% versus 15.4%).     
Ulualp et al.,9 in a controlled study employing ambulatory 24-hour double-probe 
esophageal pH-metry (with the second pH probe placed in the hypopharynx), showed that 
adults with refractory CRS had a significantly higher prevalence of pharyngeal acid 
reflux episodes.  
DiBaise et al.10 compared, using 24-hour double-probe esophageal pH-metry, the reflux 
profile of CRS patients with that of patients diagnosed with GERD, and reported that the 
pH test results of both groups were similar. However, when these sinusitis patients 
undertook a 3-month trial treatment of omeprazole b.i.d., the clinical results showed only 
modest improvement.       
Katle et al.11 had a Sino-Nasal Outcome Test 20 (SNOT-20), a nose- and sinus-related 
quality of life assessment questionnaire, submitted to one group of GERD patients and to 
a control group. They found out that the average total SNOT-20 score in patients with 
GERD was 22.1, and in the control group 9.4, meaning that that GERD patients have a 
reduced nose- and sinus-related quality of life compared to controls. 
Bohnhorst et al.12 followed a similar approach, using the SNOT-22 test (a survey 
instrument evaluating the severity of sinonasal symptoms associated with chronic 
rhinosinusitis) in a group of GERD patients and in the general population to find out that 
the prevalence of CRS among patients with GERD was 20.7%, compared to 8.5% from 
the general population. 
DeConde et al.13 administered three specific quality-of-life questionnaires (the SNOT-22, 




patients with CRS before sinus surgery and at 6, 12, and 18 months postoperatively, and 
compared the results to those from patients with (n=72) and without (n=157) history of 
GERD. They could not demonstrate that history of GERD co-morbidity increased the 
burden of CRS symptoms on quality-of-life, either for baseline characteristics or 
outcomes following surgery.              
Delehaye et al.14 evaluated 50 reflux patients undergoing gastroesophageal endoscopy, 
having them fill out a SNOT-20 questionnaire and perform a saccharin nasal mucociliary 
clearance test. A total of 74% subjects had a prolonged saccharin clearance time 
(23.79±5.58min), corresponding to the subset of patients who also had significantly 
higher, although within normal range, mean SNOT-20 scores (19.3), and presented more 
pathology during gastroesophageal endoscopy, with typical GERD complaints. The 
remaining 26% patients, with normal saccharin clearance times (8.15±2.06min), 
constituted another subset of subjects, who tended to have lower mean SNOT-20 scores 
(7.4), as well as less pathology on gastroesophageal endoscopy, and atypical, 
extraesophageal, reflux complaints.      
A different conclusion was reached by Durmus et al.,15 who also investigated if reflux 
disease is associated with nasal mucociliary transport changes. They performed a 
saccharin nasal mucociliary clearance test on 50 patients with GERD and/or LPR, and 
their results were compared to those of a control group with 30 healthy subjects. The 
study group underwent an additional saccharin nasal mucociliary clearance test after a 
12-week period of treatment with PPIs. They concluded that the study group’s 




DelGaudio,16 using triple probe pH-metry with sensors at both the hypopharynx and 
nasopharynx, demonstrated that subjects with persistent CRS after endoscopic surgery 
had significantly higher rates, compared with controls, of both GERD and LPR, the later 
including reflux episodes detected at both hypopharynx and nasopharynx sensors.  
Wong et al.17 used 24-hour four-channel pH-metry with sensors at the distal and proximal 
esophagus and at the hypopharynx and nasopharynx to find that 32.4% of the adult CRS 
population evaluated had reflux, with 23.1% of the detected episodes reaching the 
proximal esophagus, 3% reaching the hypopharynx, and only 0.2% reaching the 
nasopharynx.  They concluded that mechanisms other than a direct contact of the 
refluxate with the nasopharyngeal mucosa were probably at stake in the association 
between reflux and chronic rhinosinusitis.  
The same group18 challenged the lower esophagus of 10 volunteers without GERD or 
sinusitis with an acid infusion and observed an increase in nasal mucus production and 
general nasal symptom scores, which returned to baseline 45 minutes after the challenge. 
According to the authors, these results support the thesis of a neural reflex between the 
esophagus and the sinuses, via the vagus nerve, which would contribute to sinusitis 
pathogenesis in patients with GERD.     
Loehrl et al.19 had 20 patients with CRS undergo several LPR diagnostic tests at the same 
time. They concluded that while pH-metry showed reflux reaching the pharynx in 95% of 
the patients, the corresponding nasopharynx results correlated poorly with the pharyngeal 
results. Nasopharyngeal tissue biopsies performed to identify the presence of pepsin were 




lavage fluid showed positive results, a sure sign, according to the authors, that there is in 
fact direct contact of the refluxate with the sinonasal mucosa in these patients.  
Ozmen et al.20 confirmed that a pepsin identification test of the nasal lavage fluid seems 
to be a reliable tool to identify LPR in patients with CRS by showing 100% sensitivity 
and 92.5% specificity in comparison to 24-hour dual-probe pH monitoring. In their series 
of cases, 33 CRS subjects showed a higher rate of hypopharyngeal acid reflux events than 
20 non-CRS subjects (88% versus 55%), and the fluorometric pepsin assay they used 
proved to be a reliable noninvasive LPR screening method, alternative to pH monitoring 
(all their patients with intranasal pepsin had hypopharyngeal reflux).             
Phipps et al.21 studied children with refractory CRS using 24-hour double probe 
esophageal pH-metry and demonstrated that they have a much higher prevalence of 
GERD than the general pediatric population, with 32% clearly showing evidence of 
reflux in the nasopharynx. They pointed out that sinus disease improves for most of these 
children after treatment for GERD.  
Pincus et al.22 selected 30 adult patients with recalcitrant CRS and performed 24-hour 
either double or triple probe esophageal pH-metry, which showed reflux disease in 25 of 
them. These patients were started on a PPI, and after one month most of them had seen 
improvements in both their GERD and sinus symptoms.   
Jecker et al.23 compared the 24-h double probe pH testing data of 20 patients with nasal 
polyps with the data of 20 controls. Surprisingly, they found that the number of reflux 
episodes registered at the esophageal sensor was 10 times higher in the polyps group than 
in the controls, but the number of reflux events at the nasopharyngeal sensor was about 




A not very different conclusion was reached by Shaker et al.,24 who, using concurrent 
dual pharyngeal/dual esophageal pH-metry, found that none of the two groups of patients 
with suspected LPR pathology (reflux laryngitis and vasomotor rhinitis) had any 
significant difference in number, duration and pattern of pharyngeal acid refluxate events 
when compared to a control group. In realizing that asymptomatic controls also have 
pharyngeal acid reflux to a certain degree, these authors formulated the hypothesis that 
perhaps local protective factors in the airway mucosa hold the key in determining which 
individuals with reflux will develop symptoms.  
Wise et al.25 studied specifically the subgroup of patients who have persistent post-nasal 
drip as their most distinctive complaint, and used 24-hour triple probe pH-metry (sensors 
at the esophagus, laryngopharyngeal region and nasopharyngeal region) to evaluate three 
groups of patients: 1) patients who had undergone sinus surgery and kept complaining of 
post-nasal drip; 2) patients undergoing sinus surgery who were happy with their surgical 
results; and 3) volunteers without sinusitis. They concluded that all subjects with 
objective evidence of laryngopharyngeal and nasopharyngeal reflux at the pH<5 
threshold had post-nasal drip complaints and suggested reflux treatment for them.          
Leason et al.26 recently completed a meta-analysis study of published articles on reflux 
and CRS in the English language. They concluded that the data unequivocally support a 
significant association between reflux (both acid and non-acid) and CRS. The published 
evidence in the medical literature mostly supports a pathogenic role for reflux in CRS, 
with sinusitis patients having greater prevalence of intranasal H. pylori and acid reflux 
than subjects without the disease, and with chronic rhinosinusitis being more prevalent in 





H. pylori, Tonsils and Adenoids 
Unver et al.27 found a high rate of H. pylori colonization in tonsil and adenoid tissues 
after studying adenotonsillectomy specimens of children and young adults using a 
Campylobacter-like organism (CLO) test.  
Cirak et al.28 used PCR to detect the presence of H. pylori DNA in 30% of the 
adenotonsillectomy specimens of children, with most of them (71%) also possessing the 
CagA gene.   
Bulut et al.29  reached similar conclusions, with 24.6% of adenotonsillectomy specimens 
from children being positive for H. pylori by PCR, 58.6% of which were also positive for 
the cagA gene, the latter a specific feature seemingly associated with adenotonsillar 
hypertrophy. 
Lin et al.30 investigated H. pylori colonization in two groups of patients with different 
causes for the tonsillectomy: one group had tonsillectomy for chronic recurrent tonsillitis 
and another group for sleep-related breathing disorders. They encountered different H. 
pylori colonization patterns according to the indication; the tonsillitis group showed 48% 
H. pylori positive colonization and the sleep-related breathing disorders group only 24% 
of H. pylori positive colonization.   
Nártová et al.,31 in a group of adults with chronic tonsillitis and sleep apnea syndrome, 
encountered 80% of positive results for H. pylori by PCR in the tonsils of patients in the 
tonsillitis group, with the cagA gene detected in 25% of them, whilst the tonsillar tissue of the 
patients in the sleep apnea syndrome group had 82.7% positivity for H. pylori with 20.8% of 




the tonsils could be an etiopathogenetic factor in chronic tonsillitis and tonsillar hyperplasia 
related to sleep apnea. 
 Pitkaranta et al.,32 on the other hand, were unable to culture H. pylori from either 
adenoid tissue or middle ear fluid collected from children undergoing adenoidectomy 
and/or tympanostomy tube surgery, in spite of the fact that some of these children tested 
positive for H. pylori on serologic and fecal antigen detection tests.   
Yilmaz et al.33 investigated H. pylori presence using the CLO test in adenotonsillectomy 
specimens from 50 children, and found that they all tested negative despite positive 
results for H. pylori stool antigen and/or serum H. pylori IgG antibody for most of the 
children.  
Moreover, Di Bonaventura et al.,34 when evaluating tonsillar H. pylori colonization by 
performing a bilateral tonsillar swab in a group of patients who were undergoing 
gastroduodenal endoscopy  for dyspepsy, with 58.3% of them having documented gastric 
H. pylori infection, did not find a single positive result for the bacterium in both the 
microbiological culture and immunochemical analysis.  
Jelavic et al.35 selected the adenotonsillectomy specimens in their series that had tested 
positive in the rapid urease test (17/139) and had them cultured, but none of them grew H. 
pylori. They therefore concluded that adenotonsillar tissue does not seem to be a reservoir 
for H. pylori.  
Katra et al.,36 using PCR,  evaluated the presence of H. pylori in adenoid tissue of 
children selected for adenoidectomy who presented simultaneously LPR-suspected 
symptoms, and concurrently assessed for LPR by pH monitoring, with the proximal 




with H. pylori in their adenoid tissues had significantly more reflux episodes reaching 
their pharynx, a fact supporting the thesis that LPR episodes play an important role in H. 
pylori presence in the adenoid tissue.      
Lukeš et al.37 had tonsillar tissue collected from adult patients with either chronic 
tonsillitis, obstructive sleep apnea syndrome or tonsillar carcinoma assessed for H. pylori 
presence by culture and PCR. They found that the presence of the bacterium in the tissues 
was highly prevalent for all three pathologies, being detected in 73.91% of tonsillar 
tumors, in 70.0% of tonsillitis cases, and in 69.23% of obstructive sleep apnea syndrome 
specimens. More importantly, the gene analysis of virulence factors showed differences 
in the strains found in the oropharyngeal lymphoid tissue in these pathologies compared 
with the strains most commonly found in the stomach, with the former showing lower 
abundance of the cagA gene and presence of the less virulent vacA gene allele 
combination. This suggests that the H. pylori strains in the oro-pharynx of these patients 
could have a genotype different from that of the strains found in their stomachs.   
Bitar et al.38 compared three methods (rapid urease test, histology identification and PCR) 
for the evaluation of presence of H. pylori in children’s adenoid tissue, and reported that: 
1) there was a high number of false positive results when the rapid urease test was used to 
diagnose H. pylori presence (84% samples tested positive); 2) histologic identification 
seems unreliable to detect H. pylori in an extragastric location (16% samples showed H. 
pylori-like microorganisms); and 3) PCR seems to be the best way to identify the germ 
correctly (all the samples tested negative by PCR). These observations allowed them to 
conclude that perhaps H. pylori is not present in the adenoid tissue after all, and previous 




Abdel-Monem et al.39 estimated that the rapid urease test has a sensitivity of 100%, but a 
specificity of just 56%, whereas PCR has a sensitivity and specificity of 100%, although 16.6% 
of the population in their study tested positive for H. pylori in adenotonsillar tissue by PCR. 
Jabbari Moghaddam et al.40 compared the rapid urease test and histology in their capacity 
for identifying H. pylori in tonsil biopsy samples and concluded that the former was 
perhaps not sensitive enough as 39.6% of the samples tested positive by histopathology 
and only 14% had a positive rapid urease test.  
Najafipour et al.41 also found a poor agreement between the results from the rapid urease 
test and PCR in the detection of H. pylori in tonsil biopsy samples, reporting 48.5% of 
positive results with the former and 19.4% with the later.  
From the same group, Farivar et al.42 also reported poor agreement between PCR and 
histology in identifying H. pylori in tonsil biopsy samples, with 21.4% positive with the 
former and 18.4% positive with the latter method.   
By contrast, Aliakbari et al.43 found that, in adult patients with a diagnosis of chronic tonsillitis 
and adenoid hypertrophy, not a single one of them had a positive PCR test for H. pylori in 
adenotonsillar tissues, although 65% were found to be seropositive for H. pylori IgG and 8% 
presented digestive symptoms. In addition, neither seropositivity nor digestive symptoms 
correlated with adenotonsillar H. pylori colonization.   
Khademi et al.44 analyzed by CLO the H. pylori colonization pattern in tonsillar surface 
tissues and tonsillar core tissues and concluded that while H. pylori was present in 53% 
of the surface samples, the bacterium was only present in 23% of the core samples, with 




The authors thus warned that all H. pylori results obtained from the tonsil surface may 
not represent the tonsil core.    
A different conclusion was reached by Aslan et al.45 who found no differences in the H. 
pylori colonization pattern between tonsillar surface (42%) and core (47%) tissues using 
the Pronto Dry test. They further performed histopathology staining in the tonsillar 
samples to detect the expression of inducible nitric oxide synthase in macrophages of the 
tonsils, and concluded that its activity was significantly higher in the biopsy tissues that 
also tested positive for H. pylori, which led them to conclude that H. pylori could 
promote tonsil inflammation, if not as a causative agent then at least as a promoter of the 
inflammatory response by triggering macrophage activity.    
Skinner et al. 46 also investigated if H. pylori was associated with increased expression of 
inducible nitric oxide synthase in macrophages of the tonsil, and they indeed detected an 
increase in the number of macrophages stained for this enzyme in this tissue; this result 
related to systemic H. pylori seropositivity only, as all their tonsil tissue samples were 
negative for H. pylori.              
Kusano et al.47 demonstrated that H. pylori can be present in the palatine tonsils crypts in 
the coccoid form. In their series of tonsillar samples from 55 patients with recurrent 
pharyngotonsillitis or IgA nephropathy, 78.2% were positive for tonsillar H. pylori, 
identified by immunofluorescence and immunoelectron microscopy using antibodies 
against H. pylori. Most samples (88.4%) were positive for the cagA gene, and 27.3% of 
the patients were shown to have H. pylori gastric infection, all of whom concurrently had 




Minocha et al.48 studied patients undergoing gastro-duodenal endoscopy for varied 
reasons and identified two groups, those with and those without H. pylori gastric 
infection. By scrutinizing the patients’ background, they found out that a prior 
tonsillectomy was performed in 30.6% of the subjects in the H. pylori-negative group 
versus 5.4% of the subjects in H. pylori-positive group. They then concluded that a 
history of tonsillectomy is apparently associated with decreased prevalence of H. pylori 
gastric colonization, thus supporting the theory that tonsillar tissue is a reservoir for H. 
pylori infection.  
Opposite conclusions were, however, reached by Sezen et al.,49 who conducted a 
prospective study to determine the effect of tonsillectomy on the eradication of H. pylori 
from the gastrointestinal tract. Patients with H. pylori-positive gastric infection were 
divided into three groups: 1) those who first underwent tonsillectomy and afterwards 
received combination-drug therapy for 14 days; 2) those who first had the same treatment 
regimen and then underwent tonsillectomy; and 3) those who just received the drug 
treatment. The success of H. pylori eradication was assessed by gastroscopy after two 
months. Similar success rates were encountered in the three groups (75%, 80% and 70%, 
respectively), allowing the authors to conclude that tonsillectomy has no significant effect 
on gastric H. pylori eradication and that tonsillar tissue does not seem to be a reservoir 
for H. pylori infection.          
 
H. pylori and Otitis Media 
Pitkaranta et al.50 failed to grow H pylori after culturing both middle ear fluid and 




adenoidectomy for chronic otitis media with effusion, although 20% of the children had 
serologic evidence of a current or previous infection with the bacterium.  
Bitar et al.51 also failed to find any evidence of H. pylori by PCR in both middle ear fluid 
and adenoid tissue from children with chronic otitis media with effusion, despite positive 
results in the rapid urease test for some adenoid tissue samples. 
Ozcan et al.52 using immunohistochemistry and rapid urease testing, were also unable to 
find H. pylori in middle ear fluid and adenoid tissue, but 32 % of the children from which 
the samples derived had anti-H. pylori IgG antibody present in their blood, 12% had the 
anti-H. pylori IgA antibody, and 12% had both the anti-H. pylori IgG and the IgA 
antibody. 
By contrast, Morinaka et al.53 found that aspirated middle ear fluid samples from children 
with otitis media with effusion were almost all positive for H. pylori by 
immunohistochemistry and Giemsa staining.  Bai et al.54 used PCR and encountered 40% 
of middle ear fluid samples positive for H. pylori colonization in cases of otitis media 
with effusion. Karlidag et al.,55 also using PCR, encountered only 16.3% of positive 
samples.  
Fancy et al.,56 on the other hand, when comparing adenoid tissue and middle ear fluid 
from children with chronic otitis media with effusion with adenoid tissue from a control 
group of children with indication for adenoidectomy but no middle ear pathology, 
detected H. pylori by PCR in the adenoids and middle ear fluid in a number of patients 
from both groups. However, the difference in H. pylori-positive adenoid samples between 
the study and the control groups was not statistically significant (10/45 and 6/37), which 




middle ear effusion) of some subjects in both groups, its presence does not support a role 
for the bacterium in the pathogenesis of otitis media with effusion.  
Park et al.57 showed that if 30% of the middle ear effusions tested positive for H. pylori, 
then H. pylori colonization at the adenoid tissue level in the same patients was not 
statistically different from that in controls.      
Yilmaz et al.58 performed biopsies of the middle ear promontorium mucosa, in parallel 
with the collection of adenotonsillar tissue samples, in two groups of pediatric patients, 
one with chronic otitis media with effusion and the other with no ear disease, and 
investigated the presence of H. pylori by PCR and culture. They encountered 
significantly higher rates of H. pylori colonization in both middle ear mucosa and 
adenotonsillar tissues in the otitis media group, which led them to conclude that the germ 
may have a role in the pathogenesis of otitis media with effusion.   
Yilmaz et al.59 encountered percentages of 47% of H. pylori colonization by PCR in 
middle ear fluid samples of children with otitis media with effusion, which constitutes 
evidence of a possible role for the germ in the pathogenesis of the disease, but did not 
find any H. pylori in the adenoid tissues, suggesting that adenoid tissue does not act as a 
reservoir for the bacterium.   
Agirdir et al.60 compared a group of children who presented middle ear fluid at 
myringotomy with a group of children who had no middle ear fluid when the tympanic 
membrane was incised, and observed that 66.6% of the collected middle ear effusions 
tested positive for H. pylori in the CLO test, but none of the wash-out liquid samples of 




Aycicek et al.,61 using an animal model, concluded that H. pylori apparently does not 
play a role in the etiology of otitis media with effusion, but it may somehow contribute to 
the middle ear inflammatory process once other factors initiate it. 
Kariya et al.,62 also using an animal model, concluded the opposite: H. pylori induces a 
cascade of immunological and inflammatory changes in middle ear epithelium that 
suggests that the bacterium may play a significant role in otitis media with effusion 
pathogenesis.   
Kutluhan et al.63 investigated the possibility that H. pylori may also have a role in chronic 
suppurative otitis media, and collected middle ear tissue samples at tympano-
mastoidectomy surgery and used PCR to observe that it is possible to detect the 
bacterium in the middle ear cleft and mastoid of 7.9% of chronic otitis media patients.      
Dagli et al.,64 also working in chronic suppurative otitis media, showed that 53.6% of the 
middle ear mucosa samples of patients undergoing tympano-mastoidectomy were 
positive for H. pylori in the CLO test, with those subjects scoring higher than controls in 
the urea breath test.  
During one year, Saki et al.65 had the middle ear mucosa of all of their chronic otitis 
media cases undergoing surgery assessed for H. pylori presence by PCR. They identified 
two groups of patients: those with tympanosclerosis, 84.2% of whom tested positive for 
H. pylori, and those without tympanosclerosis, 45.4% of whom were also H. pylori-
positive. As the difference was statistically significant, and none of the other studied 
variables (including otorrhea and perforation size and location) correlated with H. pylori 
presence, the authors concluded that perhaps H. pylori has a role in the development of 





H. pylori and Sinusitis2 
The hypothesis that H. pylori can have a role of in chronic rhinosinusitis etiopathogenesis was 
first introduced by Ozdek et al.66 in 2003 after they detected the bacterium’s DNA by PCR in the 
sinus mucosa of about 1/3 of patients undergoing sinus surgery. They proposed that the finding 
could either be the cause or a consequence of the pathology.    
Almost simultaneously, Morinaka et al.,67 using a combination of PCR, rapid urease (CLO) 
test, culture, and immunohistochemical analysis and defining positivity as at least two 
positive results in different tests, reported that two subjects (18%) in their series of 
patients with CRS who underwent sinus surgery had sinonasal tissue samples that tested 
positive for H. pylori.  These two patients had, concurrently, either an evident or 
suspected H. pylori gastric infection. 
Koc et al.68  identified by immunohistochemical staining the presence of H. pylori in 20% 
of the surgical sinonasal samples of patients with nasal polyposis, whilst the samples 
collected during surgery for middle concha bullosa cases, which served as controls, were 
all negative for H. pylori. Both groups, however, displayed similar levels of IgG 
antibodies specific to H. pylori in their sera.  
Cvorovic et al.69 investigated the presence of H. pylori with a urease test and Giemsa 
staining simultaneously in the sinuses and the stomach of two groups of patients 
undergoing sinus surgery: one group had sinonasal polyposis and the other concha 
bullosa. They encountered H. pylori in 26% of the patients with polyposis, all of whom 
showed presence of the bacterium concomitantly in their stomach, whilst no patient with concha 
                                                 




bullosa tested positive for H. pylori.  They concluded that intranasal H. pylori is perhaps linked 
in some way to nasal polyposis, either as cause or as a consequence.      
Kim et al.,70 on the other hand, concluded that H. pylori probably does not play a critical role 
in CRS pathogenesis since only 25% of the patients in their series tested positive for H. pylori 
(using rapid urease testing and immunohistochemical analysis, with positive results 
confirmed by transmission electron microscopy), and that it was not possible to correlate 
severity of sinusitis (as assessed by both Lund-McKay CT-scan scores and symptom 
scores) with H. pylori  intranasal colonization.    
Ozyurt et al.71 employed PCR to detect H. pylori and its major virulence factor, cagA, in 
nasal polyps, normal nasal mucosa and laryngeal tissue samples, coming to the 
conclusion that although the bacterium DNA was present in more than half of the 
specimens from the three sources (59.4 % of nasal polyps, 70.4 % of normal nasal 
mucosa samples, and 58.6 % of larynx samples), with cagA -positive strains dominating 
in all groups, there were no statistically significant differences between the normal 
mucosa group and the other two groups.       
Burduk et al.,72 in a group of patients who tested positive by PCR for H. pylori in sinonasal 
mucosa samples and benign laryngeal pathology samples, reported that cagA-positive H. 
pylori was identified only in laryngeal tissues and not in the sinus samples, leading to the 
conclusion that H. pylori may have a role in laryngeal pathology, but probably not in 
sinonasal disease. 
Jelavic et al.73 studied prospectively two groups of patients after sinus surgery: those with 
sinonasal samples positive for H. pylori and those with negative sinonasal samples, as 




between the two groups in inflammatory status at surgery and postoperative improvement 
of subjective symptom scores, but surprisingly the H. pylori-negative patients performed 
poorly postoperatively on objective nasal endoscopic scores.  
Včeva et al.74 investigated the presence of H. pylori by PCR in sinonasal samples of two 
groups of patients, one with nasal polyposis and the other with concha bullosa, and found 
that H. pylori was present in the sinus mucosa of 28.5% of the polyposis cases whereas 
not a single concha bullosa case tested positive. H. pylori was indifferently present in the 
gastric mucosa of both groups, but H. pylori immunoglobulin G and A antibodies in the 
serum were found to be more common in polyposis than in concha bullosa patients 
(85.71% versus 53.33%), suggesting that H. pylori may have an active role in nasal 
polyposis pathogenesis.  
Nemati et al.75 employed three methods – PCR, culture, and urease test – to identify H. 
pylori in nasal specimens of two groups of patients, one with nasal polyps and the other 
with concha bullosa, deliberately excluding from the study any subject with evident 
symptoms of GERD. As no one in both groups tested positive, they concluded that there 
is no association between H. pylori and nasal polyposis in patients without GERD 
symptoms.   
Nikakhlagh et al.76 studied the presence of H. pylori DNA by PCR in the sinonasal 
mucosa of what is the largest studied population so far: 50 patients with CRS and 50 
patients with concha bullosa. They found that 18% of the samples from CRS subjects 
tested positive for H. pylori DNA, while only 4 % were positive in the control group; this 




Cedeño et al.77 studied the presence of H. pylori DNA by PCR in the maxillary sinus 
lavage fluid in a pediatric population with CRS, while simultaneously searching for the 
bacterium, using histology techniques, in the children’s adenoid tissue and for specific 
secretory immunoglobulin A against H. pylori in the saliva. They observed that none of 
the children with CRS had evidence of the germ’s presence, neither in their maxillary 
sinuses nor in their adenoids, in spite of 28.6% of them showing previous immunogenic 
contact with H. pylori in their saliva.     
In another recent study, Bansal et al.78 concluded that H. pylori seems to be associated 
with nasal polyposis, since the pathological sinus mucosa of 35 patients with nasal polyps 
showed much higher detection rates of H. pylori, by histology and immunohistochemistry, 
when compared to the normal nasal mucosa from 35 septoplasty subjects, which served 
as controls (40% versus 8.5%). Furthermore, two histopathological features in the nasal 
polyps – hyperplasia of the pseudostratified ciliated epithelium and aggregates of 
infiltrating lymphocytes – were statistically associated with local presence of H. pylori in 
the mucosa. Patients and controls also underwent stool antigen testing in the same study, 
which showed that all subjects testing positive for intranasal H. pylori had simultaneously 
positive stool antigen tests.        
The previously mentioned meta-analysis study on reflux and CRS by Leason et al.26 also 
presented data on H. pylori in sinonasal tissues from all the 10 case-control studies 
published until January 2015. Assessing, using various methodologies, sinonasal H. 
pylori presence in 265 subjects with CRS in comparison to 188 healthy individuals, the 
meta-analysis found an increased odds ratio (OR) of H. pylori in CRS (OR 2.88) overall, 




both intranasal H. pylori and GERD were evaluated revealed that 87.5% of subjects with 




HYPOTHESIS AND GOALS OF THE INVESTIGATION  
The data generated so far supports for and against arguments for an eventual role for LPR 
and H. pylori in inflammatory diseases of the upper aerodigestive and respiratory tract, 
including CRS.  
The reported clinical improvement seen in a number of cases after anti-reflux or anti- H. 
pylori therapy appears to be a rather convincing, albeit totally empirical argument, but the 
documentation of LPR and H. pylori in the aerodigestive and respiratory tract seems to be 
still plagued by many unresolved methodological issues and does not necessarily 
establish a causal link to airway inflammatory disease.  
Definitely, a final word on the subject has not been said yet, and the current data are closer to 
establish that an association between both LPR and H. pylori and CRS does in fact exist, than 
to enlighten us on the nature of that association.  
We test here the hypothesis that LPR and its contents, including H. pylori, are in some way 
associated with chronic inflammatory disease of the upper respiratory tract, and we chose 
chronic inflammatory disease of the paranasal sinuses as the target disease model for the 
investigation.  




1) To investigate the relative role of LPR contents, H. pylori, pepsin and pepsinogen 
I in the development of sinonasal inflammation in a case-control study of patients 
selected for sinus surgery due to chronic medically refractory rhinosinusitis. The 
results obtained from patients with chronic rhinosinusitis are to be compared to 
the results of individuals with concha bullosa, serving as controls.   
2) To investigate the relative role of H. pylori in the development of sinonasal 
inflammation, comparing the bacterium’s presence in the nose with its gastric 
colonization pattern, in a cohort study of patients selected for sinus surgery due to 
chronic medically refractory rhinosinusitis.      
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OBJECTIVE: Investigation of the potential role of several laryngopharyngeal reflux 
contents in sinus disease.  
STUDY DESIGN AND SETTING: A controlled cohort analysis of Helicobacter pylori, 
pepsin and pepsinogen I in inflamed and non-inflamed sinonasal tissue. Fifteen patients, 
selected for surgery due to chronic medically refractory rhinosinusitis, had their 
pathologic sinus tissue analyzed for polymerase chain reaction detection of H. pylori 
DNA and assayed for pepsin and pepsinogen I tissue concentration levels. A control 
group of 5 subjects undergoing surgery for anatomic sinonasal abnormalities provided 
non-inflammatory mucosa specimens for comparison. 
RESULTS: H. pylori was found scattered in inflamed and non-inflamed mucosa, 
whereas sinonasal tissue pepsin/ pepsinogen never rose above blood levels in both groups.  
CONCLUSIONS: Evidence of intra-operative peptic reflux into the sinuses was not 
found. As H. pylori was similarly encountered in healthy and diseased sinus mucosa, it 














Gastric reflux has been incriminated recently in a myriad of laryngeal and other supra 
esophageal symptoms,1,2 a much debated topic under the banner name of 
laryngopharyngeal reflux (LPR) disease. Patients with clinical LPR undergoing pH 
monitoring have documented acid reflux intermittently present in their pharynx, which 
can sometimes be traced as high in the airway tract as the nasopharynx,3-5 with gastric 
pepsin being detected even in middle ear effusion of children with secretory otitis media.6 
Due to the protean nature of LPR symptoms, a host of controversies remain.2 A 
hypothetical relation between LPR and chronic inflammation of the nose and sinuses was 
further added to the debate, in acknowledgment of the fact that both conditions intersect 
fairly consistently in clinical practice.7-9 Reports of improvement of chronic sinusitis in 
children after anti-reflux therapy apparently support this relationship,4,10,11 whereas 
omeprazole is able to reputably improve symptoms of refractory chronic sinusitis in 
adults.12   
A number of pathophysiologic mechanisms for LPR symptoms have been proposed. 
Because Helicobacter pylori is prevalent in gastric contents, this organism has also been 
added to the list of potential role players in reflux-induced supra esophageal mucosa 
injury. H. pylori was declared a likely laryngeal pathogen13 and its presence was also 
detected in diseased sinonasal tissue.14,15 Thus far, however, no well designed controlled 







MATERIALS AND METHODS 
Fifteen, 11 male and 4 female, adult patients, aged 18 to 79 (mean 49.9 years), requiring 
endoscopic sinus surgery due to medically recalcitrant chronic rhinosinusitis involving  
the anterior and the posterior ethmoid on at least one nasal cavity, with or without 
simultaneous sphenoid sinus disease, were enrolled as a study group (Figure 1). Informed 
consent was obtained from each patient and the study protocol was subject to approval by 
the institutional ethics committee. All subjects had their biochemical and hematological 
profiles within the normal range, with the exception of mild to moderate eosinophilia 
found in some atopic patients. Patients with cystic fibrosis, immotile cilia syndrome and 
known immunodeficiencies were excluded. In all subjects the inflammatory nature of the 
disease was confirmed subsequently by hystopathologic examination. 
Five, 1 male and 4 female, adult patients, aged 22 to 72 (mean 37.6 years), requiring 
endoscopic sinus surgery due to endonasal anatomic variations (symptomatic concha 
bullosa) that did not produce CT scan detectable sinus inflammation, were enrolled as a 
control group (Figure 2). 
In the immediate pre-operative period of all subjects, drug therapy for any underlying 
condition was allowed, including systemic steroids for asthma management. Excluded 
from the investigation, however, were patients who undertook antimicrobial therapy of 
any kind, including in prophylaxis, in the last weeks before surgery. Also, no patient had 
undergone treatment with antacids, histamine2 -receptor antagonists, prokinetic agents, or 
proton-pump inhibitor in the recent pre-operative period. No patient had a history of prior 




Surgery was performed under general anesthesia, with orotracheal intubation. No patient 
required nasogastric tube placement and vomiting did not occur, pre- or intra-operatively, 
according to anesthesia chart review.       
In both groups, blood samples (7ml) were collected immediately before induction of 
general anesthesia. Serum was separated by centrifugation and immediately frozen at –
70ºC until assayed. Concentrations of pepsin and pepsinogen I were subsequently 
determined, the former by an immunoassay with rooster polyclonal antibodies to purified 
human pepsin, 16 the latter by radioimmunoassay.17  
Preceding the intervention, routine vasoconstriction of the nasal mucosa to minimize 
intra-operative bleeding, was carried out, including infiltration, at critical sites, with 1% 
xylocaine with 1:100,000 epinephrine. 
During surgery tissue samples of sinonasal mucosa were collected in the study group at 
the anterior ethmoid (including material taken from the uncinate process, ethmoidal bulla 
and meatal portion of the middle turbinate), the posterior ethmoid; and, eventually, C) the 
sphenoid sinus. The extent of the pathology on the CT scans determined which sites were 
to be surgically addressed, but pathology at anterior and posterior ethmoid on at least one 
side of the nose, with or without associated sphenoid disease, was required for study 
enrollment (Figure 1). 
In the control group, tissue samples were collected both from the meatal portion of the 
middle turbinate of the concha bullosa, which served as anterior ethmoid specimen, and 
from a donor site of healthy, posterior ethmoid, mucosa on the same side of the nose 
(Figure 2). The latter specimens were collected through a small opening at the basal 




function. One or both sides of the nose were addressed this way according to pre-
determined require-to-treat surgical planning. Site inflammation was ruled out 
subsequently by hystopathologic examination, whereas post-operative endoscopic control 
warranted that proper healing occurred in all operated sides.  
In both groups, the mucosa specimens collected at all the different sinonasal sites were 
immediately frozen at –70ºC and assayed subsequently for 1) pepsin and pepsinogen I 
concentration levels, using an immunoassay with rooster polyclonal antibodies to purified 
human pepsin16 and radioimmunoassay methodology,17 and for 2) polymerase chain 
reaction (PCR) extraction and amplification of genomic H. pylori DNA.18 The method, 
described elsewhere,17 employed the PCR – based microtiter plate hybridization 
technique with primers targeted to an ureA gene segment of H. pylori. The sensitivity of 
the method is 10 bacterial cells, with 100% specificity.    
Statistical analysis employed the following tests according to specific requirements: the 
Mann-Whitney test, Wilcoxon Signed-Rank test, paired-samples t test, Pearson’s chi-
square test, Fisher’s test and the McNemar test. For all, a significance level was set at p 
= .05.   
 
RESULTS 
Control group patients are mostly female and younger in age and study group patients 
seem biased toward the male gender and have higher rates of allergy, asthma and aspirin 
intolerance co-morbidity. However any statistic analysis comparisons of the 





Figure 3 illustrates the study group mean concentration results and standard deviations of 
pepsin and pepsinogen I in serum and in sinonasal tissue. The tissue/ blood ratio for both 
pepsin and pepsinogen I was 0.17. No statistically significant differences were found 
between patients and controls regarding blood and mucosa pepsin and pepsinogen I 
values. Sex, site, nasal side, disease extension, and co-presence of allergy, asthma and 
aspirin intolerance, were not found to have an influence on the sinus tissue concentration 
levels of both enzymes. Age, however, was found to influence, as older patients tend to 
have higher sinonasal concentrations of both pepsin (p= .007) and pepsinogen I (p= .03). 
Table I displays the results of H. pylori distribution per patient and surgical site in all 
subjects. From the 69 tissue samples collected in the study group 19% were positive for 
H. pylori infection, whilst from the 12 tissue samples collected in the control group 8% 
were H. pylori positive. No statistically significant differences were encountered in H. 
pylori colonization between diseased mucosa and control sinonasal tissue. Also, in both 
groups, no variable, such as age, sex, nasal side, site, disease extension, co-presence of 
allergy, asthma or aspirin intolerance, was found to relate to bacterial colonization. Even 
concomitant pepsin and pepsinogen I tissue levels were not found to statistically relate to 
H. pylori presence in any specific site, in both groups. 
DISCUSSION 
Our study shows that the concentrations of pepsin and pepsinogen I in the sinuses are in 
fact no higher than the pepsin and pepsinogen serum levels, with no single mucosal result 
ever exceeding blood concentrations. As the extracellular fluid in chronically inflamed 
sinonasal mucosa results from plasma transudation processes, we needed to clarify if the 




simply, pepsin derived from plasma pepsinogen. The latter seems to be the case, as 
pepsin tissue levels are compatible with plasma transudation of pepsinogen into the sinus 
mucosa rather than a gastric reflux transport of the enzyme into the nose, in which case 
values up to 1000-fold the serum levels can be expected.6 This finding does not preclude 
the possibility that gastric contents may reflux into the nasal cavity in LPR patients. 
Merely that no evidence of refluxate reaching the nose and sinuses could be documented 
during the time these patients were in surgery under general anesthesia. A conclusion that 
perhaps should not surprise since LPR patients are typically upright position daytime 
refluxers,2 and as few as three reflux episodes per week are apparently sufficient to 
produce ongoing inflammation at the highly sensitive supra esophageal mucosa.1,2    
Our study also reveals that H. pylori is present in the sinonasal mucosa of a significant 
number of chronic rhinosinusitis surgical specimens. These results are in agreement with 
data published previously,14,15 the occurrence perhaps being even more prevalent than  
reported.14 The fact that, in our series, pre-operative antimicrobial prophylaxis was 
avoided and no patient was taking H2  -receptor antagonists or proton- pump inhibitors 
prior to surgery, may have enhanced the diagnosis sensitivity. The study design also 
allowed for a mapping distribution of the organism within the sinonasal cavity, which, 
however, did not reveal any particular pattern of colonization. Therefore the posterior 
sinuses (i.e., posterior ethmoid and sphenoid sinus) are at no greater risk of being 
colonized by the organism than the anterior ethmoid, as gastric backflow mechanism 
would have it. Unless unforeseen factors have biased our data (i.e., lidocaine has been 




chronic rhinosinusitis has a patchy distribution and does not seem to follow an 
established pattern.  
The pathophysiology of LPR disease is a much debated topic, with the mechanisms direct 
peptic-acid injury and triggered neurophysiological changes, cited most frequently.2,9 The 
possibility that Helicobacter pylori may also play an etiopathogenic role was only put 
forth very recently.14,15 This organism is prevalent in the gastric contents of a large 
number of humans worldwide.19 Once infected, adults will maintain lifelong H. pylori 
colonization, until eradication by specific therapy.19 Gastric infection is characterized by 
a non-invasive mucosal surface attachment of the bacterium that triggers a specific host 
response, involving neutrophils, T and B lymphocytes, plasma cells, and macrophages, 
ultimately leading to tissue damage.19 Although expressed clinically in highly variable 
ways, virtually all H. pylori -infected persons have chronic superficial gastritis, often 
displaying a patchy distribution at the stomach mucosal surface19 (not unlike the 
colonization pattern found in the sinuses). 
Since a significant number of gastroesophageal reflux disease (GERD) patients are 
infected with H. pylori, and the infection seems to disturb lower oesophageal sphincter 
function,19 the hypothesis of a refluxate-conveyed bacterial seeding of the 
supraesophageal mucosa in LPR patients is perhaps not too far-fetched. It has been 
suggested that the reflux of infected gastric juice into the nasopharynx may produce 
airway mucosal edema and inflammation from the combined activity of the peptic–acid 
injury and local H. pylori infection.14 A direct relation between the severity of the 
mucosal inflammation and sinus H. pylori colonization rates can even be argued for, 




pathology, as opposed to medical-only failures from our studied population, thus 
apparently with more severe sinus disease, have been shown to suffer from an increased 
prevalence of LPR.5 The < 100%-positive bacterial identification rate scenario we have 
identified in the inflamed sinus mucosa could also be mimicking what is reported to 
occur at other colonization sites in the body: that repeated and extensive sampling is 
frequently required to ensure that a certain diagnostic methodology does not miss out on 
the H. pylori mucosal infection. And if the T helper (Th) 1-associated H. pylori-
inflammation at the stomach19 seems at odds with the Th2 eosinophilic pattern that 
histopathologically hallmarks chronic rhinosinusitis at the nose, one should acknowledge 
possible similarities between the latter and an entity called eosinophilic esophagitis. 20 
The latter often mimics GERD but is characterized by a lack of response to acid 
suppression,20 a feature shared with severe LPR.  
Any relation, however, remains speculative. At no other location than the gastric mucosa 
was H. pylori found to cause disease, although the organism was also detected in saliva, 
dental plaque, adenoids and tonsils.19 The presence of the bacterium in the sinuses may 
even be the result of a direct transmission of the infection from any of these sites into the 
nasal cavity. If the role of H. pylori in extragastric locations is presently unclear, some 
believe they serve as reservoir sites for gastric re-infection, as recurrence after 
antimicrobial therapy is not uncommon.19 The fact that in our study, H. pylori 
colonization was not statistically found to be more common in sinusitis patients than in 
controls, lends credibility to the nose as a reservoir thesis. Whether the nose acts as a 
permanent or a transient extra-gastric settling place for the organism is not known, the 




organism in sinonasal mucosa we have found. Thus, potential clinical benefits of anti-
reflux therapy in chronic rhinosinusitis4,10-12 seems more likely to result from the 
suppression of the LPR-induced, peptic-acid or neurologic, pathogenic effects on the 
upper airway mucosa, rather than from an influence on the nose and sinuses’ H. pylori 
colonization. Although we acknowledge that our studied population is perhaps too small 
in size to allow a definitive word on this matter, our conclusions are nevertheless 
remarkably consistent with the recent concept that, when in co-morbidity, the pathogenic 
mechanisms of H. pylori infection and reflux disease probably run in a parallel fashion, 
independent from each other.19    
CONCLUSION 
If the role of H. pylori infection in gastroduodenal disease is unquestionable, the manner 
by which the organism is transmitted remains unclear. To the established fecal-oral and 
oral-oral routes, newer routes of transmission have been proposed such as gastric-oral 
and, more recently, gastric-nasal transmission, the latter the aim of our investigation. H. 
pylori DNA may be encountered in chronically inflamed sinonasal mucosa, possibly as a 
manifestation of LPR disease, although at this time we can only speculate on the 
bacterium’s doings at this particular location. The possibility that it plays some 
etiopathogenic role in rhinosinusitis can not be dismissed too lightly, as theoretically 
there is some valid reasoning behind it. Our data, however, does not seem to substantiate 
a pathogenic presence of the organism in the nose. At the sinonasal mucosa H. pylori 
more likely has a reservoir function similar to other extragastric, upper aerodigestive, site 


















Figure 1. CT-scan of a typical study group patient, with extensive chronic inflammatory 
sinus disease requiring surgery for bilateral anterior (* left hand-side on the axial plane) 
and posterior ethmoid (**) sinuses pathology, with sphenoid sinusitis on the right hand-
side.  A total right sphenoethmoidectomy with total left ethmoidectomy was performed, 
which provided diseased tissue samples from the right and left anterior ethmoids, right 
and left posterior ethmoids, as well as right sphenoid sinus. The left sphenoid sinus (***), 

















Figure 2. CT-scan of a typical control group patient, requiring surgery for a symptomatic 
left concha bullosa (* axial plane), but without imaging evidence of inflammation in any 
part of the sinuses. The meatal mucosa of the partially ressected middle turbinate, 
signaled by the arrows, was labeled non-inflamed anterior ethmoid sample, whereas a 
posterior ethmoid non-inflamed mucosa sample from the same side (**) was collected 
through a small opening at the basal lamella.  The right side of the nose was not 













Figure 3. Mean concentration levels and standard deviations of pepsin and pepsinogen I 
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Background: The role played by Helicobacter pylori in the sinuses, and its association 
with the same organism’s gastric infection, are still unclear.  
Methods: In order to compare H.pylori colonization patterns in the nose and stomach we 
conducted a cohort analysis of 14 patients, eligible for sinus surgery due to chronic 
medically refractory rhinosinusitis, who were tested for simultaneous presence of H. 
pylori, by histology, culture and polymerase chain reaction, in pathologic sinus tissue 
collected during surgery and in gastric mucosa obtained through gastroduodenal 
endoscopy.  
Results: H. pylori DNA was found in the sinus mucosa of 15.4% of patients with chronic 
rhinosinusitis, and all of them showed concurrent H. pylori stomach infection. Sinus 
colonization was not found without simultaneous gastric colonization, although most 
patients with gastric infection did not have the bacterial DNA in their sinuses. H. pylori’s 
presence in the nose was not associated with local inflammatory status, and no cultures 
could be obtained from any of the sinus tissue samples, including those positive for H. 
pylori DNA.    
Conclusions: Only H. pylori DNA, and not the culturable active form of the 
microorganism, could be found in the sinus mucosa of some patients with H. pylori 
gastric infection. We could not find evidence, however, that the bacterium’s presence in 









Helicobacter pylori DNA has been detected in a number of extra-gastric locations, such 
as the oral cavity, tonsils and adenoids,1,2 and even the middle ear and paranasal sinuses.2-
15 However, the significance of the microorganism’s presence at these aero- digestive and 
respiratory sites is still unclear. It is believed that the oral cavity is an important reservoir 
for H. pylori, that contributes to the oral-oral route of transmission and acts as a source of 
stomach re-infection.1 Others suggest that the bacterium may be capable of causing 
damage to the aero-digestive and respiratory mucosa in the same way it does to the 
gastric mucosa.1 However, this capacity for extra-gastric disease remains unproved, and 
some authors argue that it even seems unlikely. In order to initiate tissue damage,  not 
only does H.pylori require a set of events unique to the gastric milieu, but also culturable 
active forms of H. pylori have only been recovered outside the stomach in the aero-
digestive tract in the vicinity of the upper esophagus (i.e. in tracheal secretions in 
intubated patients), and never as far away as the bronchi, lung, or the upper respiratory 
tract.2 That far from the stomach, only the microorganism’s DNA suggests the presence 
of H. pylori at such locations.   
We conducted the present investigation in order to see how H. pylori colonization 
patterns in the nose and stomach are associated in chronic rhinosinusitis patients, as a 
way to also provide information on the eventual existence of an interaction between two 
seemingly unconnected pathologies, one in the digestive tract and the other in the upper 
respiratory tract. At the same time, we assessed if this known gastric pathogen has the 





MATERIALS AND METHODS 
A total of 14 adult patients, 8 male and 6 female, aged 30 to 68 years (mean 48.1 years), 
requiring endoscopic sinus surgery due to medically recalcitrant chronic rhinosinusitis, 
with and without nasal polyposis, were enrolled in a consecutive, unselected manner. 
Informed consent was obtained from each patient, and the study protocol was approved 
by the institutional ethics committee. All patients had their biochemical and 
hematological profiles within the normal range, with the exception of mild-to-moderate 
eosinophilia in some atopic patients. Patients with cystic fibrosis, immotile cilia 
syndrome, and known immunodeficiencies were excluded. The inflammatory nature of 
the disease was subsequently confirmed by histopathologic examination in all patients 
enrolled. 
Drug therapy for any underlying condition was allowed, including systemic steroids for 
asthma management. Antibiotic use in the 3 months prior to surgery was also noted. 
Moreover, patients were specifically asked about their history of prior H. pylori infection 
diagnosis and treatment, as well as current medication with antacids, histamine 2 -
receptor antagonists, prokinetic agents, or proton-pump inhibitors (PPI’s).  
In the immediate pre-operative period (from 1 to 10 days pre-op), all subjects underwent 
a 13C-labelled urea breath test. 
Surgery was performed under general anesthesia, with orotracheal intubation. Routine 
vasoconstriction of the nasal mucosa was carried out to minimize intra-operative bleeding, 
including infiltration, at critical sites, with 1% xylocaine with 1:100,000 epinephrine. 
The extent of the pathology on the computed tomography scans determined which sites 




roughly symmetrical extension of the pathology, according to the Lund-McKay 
classification.16 During surgery, tissue samples of diseased sinonasal mucosa were 
collected at the anterior ethmoid (including the uncinate process, ethmoidal bulla, and 
meatal portion of the middle turbinate), and the posterior ethmoid sinus from one, 
randomly chosen, nasal cavity. The collected sinus specimens were subjected to: 1) 
histopathological examination, to assess the overall degree of local inflammation (graded 
as 0+, no inflammation; 1+, mild; 2+, moderate; and 3+, severe inflammation, depending 
on the inflammatory infiltrate cell density)17; 2) microbiological culture, to isolate H. 
pylori; and 3) polymerase chain reaction (PCR) to amplify genomic H. pylori DNA.  
Enrolment required that the patients also agree to undergo a simultaneous upper 
gastrointestinal endoscopy, irrespectively of digestive symptoms. Biopsies were taken 
from the stomach mucosa lining, either from endoscopic-assessed suspected sites or 
iteratively, from the lesser or greater curvature of the antrum and the greater curvature of 
the corpus. Patients underwent gastroduodenal endoscopy either simultaneously with the 
sinonasal mucosa sampling (intra-operatively, under general anesthesia, while waiting for 
the vasoconstriction effect to occur in the nose) or up to two weeks post sinus surgery. 
The collected gastric biopsy specimens from the two sites, the antrum and the corpus, 
were analyzed by: 1) histopathology, to assess the overall degree of local inflammation 
(graded as 0+, absent; 1+, mild; 2+, moderate; 3+, severe inflammation, depending on the 
inflammatory infiltrate cell density); 2) histology to identify H. pylori in Warthin-Starry 
silver stained gastric mucosal biopsies, (also graded as 0+, no bacteria found; 1+, mild ; 
2+, moderate; 3+, severe density colonization); and 3) microbiological culture of gastric 




All sinus and stomach tissue samples were collected aseptically, transported to the 
laboratory at 4ºC in Portagerm pylori (bioMérieux, France), and processed less than four 
hours after collection. For microbiological culture, a drop of tissue macerate was plated 
onto H. pylori-selective medium (Brucella supplemented with 10% horse blood and 
Brucella supplemented with 10% horse blood and Oxoid H. pylori-selective supplement 
(Dent) ) and incubated at 37ºC in a microaerophilic atmosphere (Campygen, Oxoid) for 
up to 15 days. Colonies were then tested for urease, catalase and oxidase, and motility 
and were stained with Gram stain. 
For PCR testing, two sets of primers targeting the 16S rRNA and 23S rRNA genes of H. 
pylori were used, chosen to maximize detection as together they target sequences 
common to virtually all H. pylori strains.18,19 The first primer pair, PCR-G, amplifies a 
780bp fragment from the 16S rRNA gene specific for the Helicobacter genus, Helico F – 
5’ CTATGACGGGTATCCGGC  3’ and Helico R – 5’ CTCACGACACGAGCTGAC 3’. 
(18) The second primer pair, PCR-S, amplifies a 267 bp fragment from the 23S rRNA 
gene of the H. pylori, HPYS - 5´ CGCATGATATTCCCATTAGCAGT 3’ and HPYA - 
5’ AGGTTAAGAGGATGCGTCAGTC 3’.19 Ethidium bromide-stained agarose gel 
electrophoresis was employed for separating the PCR products according to their size. 
When interpreting the results, we considered a positive genus-specific PCR test a sign of 
presence of DNA for one of the various Helicobacter species, whilst the combination of a 
positive genus-specific with a positive species-specific PCR test was taken as a clear sign 
of presence of the actual H. pylori species.  
For histological identification of H. pylori in paraffin sections of sinus tissue, the 




The grading of the histological material, as well as all the molecular biology procedures, 
were performed after the identification of the samples was masked.       
Statistical analysis employed descriptive statistics and the Spearman's rank correlation 
coefficient (Spearman's rho).  
RESULTS 
The study group included 8 patients with asthma, 6 with allergic rhinitis, and 2 with 
intolerance to nonsteroidal anti-inflammatory drugs (NSAIDs). Other co-morbidities 
included: hypertension (n=2), hypothyroidism (n=1), goiter (n=1), angioma of the liver 
(n=1), ankylosing spondylitis (n=1), fibromyalgia while on NSAID’s (n=1), 
gastroesophageal reflux disease (GERD) (n=2) and chronic gastritis (n=1). Two patients 
were undergoing revision sinus surgery, and three admitted having taken an oral 
antibiotic in the immediate three months prior to surgery. One subject had history of H. 
pylori gastric infection treatment, while five were taking a PPI until the day before 
surgery. The patient with ankylosing spondylitis was under treatment with sulfasalazine 
at the time of the surgical procedure, and the stiffness of his entire spine was so severe 
that the gastroenterologist was unable to perform the required gastroduodenal endoscopy, 
even under general anesthesia. Another patient underwent upper gastrointestinal 
endoscopy outside of the time frame imposed by the strict study criteria (either intra-op 
or up to two weeks post sinus surgery), so the gastric results were excluded from the 
analysis. Two patients had histology results for one gastric site only, and in one patient 
the gastric histological results were altogether absent.        
The inflammatory status of the sinus mucosa at the time of surgery for each patient is 




inflammation was found in 50% (n=5) of the asthmatics and in 16.6 % (n=1) of the non-
asthmatics, whilst mild inflammation was encountered in 50% (n=4) of the asthmatics 
and in 83.3 % (n=5) of the non-asthmatics. A total of 60% (n=3) of patients in the 
moderate sinus inflammation group had allergic rhinitis, while mild inflammation was 
observed in 50% (n=3) of the patients with a diagnosis of allergic rhinitis. All patients 
with intolerance to NSAIDs in the study group displayed moderate sinus inflammation.  
Moderate sinus inflammation was also encountered in 66.7% (n=2) of the patients who 
had taken an antimicrobial agent in the three months prior to surgery, whilst mild 
inflammation was mostly found (72.7%, n=8) in patients who had not recently needed 
antibiotic treatment. 
The only patient who had prior treatment for H. pylori gastric infection displayed 
moderate sinus inflammation, while, among the five patients who were on PPI’s at the 
time of surgery, three showed mild sinus inflammation and two moderate sinus 
inflammation. 
Table 1 shows the results of the gastric and nasal inflammatory and H. pylori infection 
status for all patients.  
All patients were found to have some degree of gastric inflammation, fitting the 
histopathological diagnosis of chronic non-atrophic gastritis (active or non-active), even 
when the endoscopist failed to identify inflammation and performed iterative biopsies.  A 
total of 60% of the antrum biopsies showed moderate inflammation, with mild 
inflammation occurring in 40%, whereas in corpus biopsies 70% had mild and 30% 




Histological identification of H.pylori in gastric mucosa biopsies of the antrum was 
negative in 50% of the cases (n=5), revealing mild infection in 10% (n=1), moderate 
infection in 10% (n=1), and severe infection in 30% of the cases (n=3).  For the corpus 
biopsies, the results were negative in 50% (n=5), with mild infection in 10% (n=1), 
moderate in 30% (n=3), and severe infection in 10% (n=1). 
The results of cultures of gastric mucosa biopsies were positive for H.pylori in 66.7% of 
the cases (n=8), whilst the PCR-G test was positive in 54.5% (n=6) of the antrum samples 
and in 50% (n=5) of the corpus samples, and the PCR-S test was positive in 72.7% (n=8) 
of the antrum samples and in 66.7% (n=8) of the corpus samples.   
A total of 66.6% of the patients receiving PPI treatment were H. pylori negative.  
Table 2 shows the correlations between the variables found to have statistical significance.  
Regarding H.pylori presence in the sinonasal mucosa, the species-specific PCR 
identification was positive in only two cases (15.4%), although 69.2% had sinonasal 
samples with positive genus-specific PCR results. The first case of positive H.pylori 
DNA in the sinuses had a positive breath urea test and tested positive for H.pylori in the 
stomach by histology, bacterial culture and PCR.  The second case, however, had a 
negative breath test and tested negative for gastric H.pylori by histology and bacterial 
culture, but the species-specific PCR identification test in the stomach was positive 
(result confirmed at a different laboratory).   
All attempts to grow H.pylori in culture medium from sinonasal samples failed.  
DISCUSSION 
The characteristics of our investigation, with patients undergoing simultaneous extensive 




necessarily restricts the number of patients enrolled in the study, and as a result may not 
be able to show statistical significance. The available data, however, are sufficient to 
allow for important conclusions.    
Since urease production is a hallmark of active gastric infection, it is perhaps no surprise 
that most, but not all, patients in our study with a positive urease breath test had indeed H. 
pylori gastric infection, confirmed by histopathology, culture, and/or PCR testing. The 
breath test was positive in one case where H. pylori was detected in the sinuses, but was 
negative in the other. As the majority of patients in our study had positive breath tests and 
no evidence of H. pylori in their sinuses, this apparently renders the test unsuitable for the 
specific identification of the bacterium in the nose. 
Our data actually reveals that, in spite of the relevant number of patients with positive 
Helicobacter-genus DNA detected by PCR in the sinus mucosa (which certainly merits 
separate investigation), specifically H. pylori DNA was only found in the sinonasal 
mucosa of about 15.4% of chronic rhinosinusitis surgical patients. These results are in 
agreement with previously published data.3-15 Admittedly, this prevalence could indeed 
be greater if the bacterium in the nose would follow a similar mosaic pattern of mucosal 
infection as in the stomach, with patches of diseased mucosa alternating with non-
infected normal mucosa, in which case it would require repeated and extensive sampling 
to allow for a positive H. pylori result (five different sites, according to some).20   
Both cases with H. pylori DNA in the sinuses had H. pylori DNA simultaneously present 
in their stomachs, but only about 25-28.6% of the patients with positive gastric species-
specific PCR tests had H. pylori DNA in their sinuses.  This suggests that if the bacterium 




not all H. pylori gastric infections are necessarily associated with H. pylori colonization 
of the sinuses.   
Our data show that while there is a positive correlation between cultural and histological 
identification of H. pylori in the stomach and gastric inflammation, we found no such 
correlation between H. pylori and site inflammation in the nose (Table 2). Therefore, it is 
perhaps not farfetched to admit that H. pylori presence in the nose and sinuses does not 
contribute to local mucosal inflammation.  
The co-diagnosis of allergic rhinitis, asthma or intolerance to NSAIDs, was not found to 
statistically relate to either positive or negative sinonasal H. pylori results, suggesting that 
sinonasal H. pylori colonization may occur regardless these co-morbidities are present or 
not.  
Critically, H. pylori could only be recovered from the nose in the DNA form, as all the 
attempts to culture the bacterium from nasosinusal sites failed. This inability to culture H. 
pylori could be due to the presence of too few microorganisms to be detected, or the 
simultaneous presence of too many types of other bacteria in the nose that inhibit growth 
of H. pylori. However, it has been shown that the bacterium can be cultured from adverse 
environments such as the air sampled during vomiting or from a tracheostomy tube.2 So it 
is admissible that the reason may not have to do with the method but with the possibility 
that, in the sinuses, either the organism is represented just by fragments of its DNA and 
that these are destined to transiently remain there just for a limited time, or the 
microorganism is, in fact, in a dormant state that precludes culture, and is destined to 




The bacterium is, indeed, known to be able to resist harsh environments by changing to a 
dormant, inactive state, a non-culturable coccoid form that could still be potentially 
viable, later on, in the stomach.21,22 It is therefore possible that H. pylori may lay dormant 
for long periods of time, using the nose and the sinuses as reservoirs, waiting for an 
eventual return to an active form, either to cause gastric re-infection or to participate in 
the oral-oral route of transmission. The fact that in a previous study no statistical 
difference was observed between H. pylori nasal colonization in patients with sinusitis 
when compared to the control group,6 lends credibility to the ‘nose as a reservoir’ thesis, 
and reinforces our conviction that the bacterium’s presence in the nose does not 
contribute to the local inflammatory status.  
To account for the bacterium’s presence in the nose, the hypothesis of gastric-nasal 
transmission seems the most logical explanation since a significant number of patients 
with GERD and laryngopharyngeal reflux (LPR) also have H. pylori gastric colonization. 
It has been shown that the microorganism has a positive tropism for mucins23 – and 
mucins cover and protect the sinus and mouth epithelia24 – and is also able to invade 
epithelial cells.25 The presence of H. pylori in the sinuses could then be regarded as a 
biomarker of the extent of LPR in the upper airway tract. However, at this time, we have 
no definitive proof of this, and we simply cannot rule out the possibility that the 
bacterium may use, in alternative or in conjunction, other routes to have its DNA reach 
the sinuses, for instance, via lymphatic or vascular transmission, from either the stomach 
or any other extra-digestive site.     
Also, the fact that the presence of H. pylori in the sinuses apparently does not support a 




influence the course of an inflammatory disease of the sinuses.  H. pylori gastric infection 
is known to cause a vast array of systemic effects, including a strong immunologic 
response and gastrin and cytokine release from the stomach mucosa, all of which may 
indirectly affect chronic inflammation in any part of the respiratory system.2 Definitive 
proof of the clinical relevance of these H. pylori–induced systemic effects is, however, 
still lacking.     
CONCLUSION 
Our results suggest that, regardless of how H. pylori reaches the sinuses, its presence 
there does not seem to contribute to the local inflammatory status of the respiratory 
mucosa.  The fact that H. pylori  could not be cultured from nose samples and is only 
present in its DNA form, suggests either a transient presence of parts of its genome in the 
sinuses, or, instead, what could be seen as a defensive adaptive reaction in preparation for 
a more or less lengthy stay at an inhospitable location, a change to a viable non-culturable 
form, from which H. pylori could hypothetically regain activity, to either play a role in 
the oral-oral route of transmission or in an eventual gastric re-infection. 
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To comprehend why such a wide range of results and opposite conclusions concerning 
LPR, H. pylori and chronic inflammatory sinus disease exist in the medical literature, one 
must first understand the very nature of the digestive pathology at stake and the intrinsic 
value of each diagnostic test employed in its assessment. Reflux is an intermittent 
phenomenon, which may cause chronic upper respiratory tract inflammation through a 
direct and/or indirect effect, via vagal reflexes, on the respiratory mucosa. Pepsin seems 
to play a crucial role, and it has been shown that it remains active at pH values 
significantly higher than those in the stomach, which makes nonacid reflux probably no 
less pathogenic to the upper respiratory mucosa than acid reflux. Esophageal pH 
monitoring is still considered the gold standard for GERD diagnosis, but clinicians are 
still awaiting more appropriate tests for the specific diagnosis of LPR. If GERD is a 
hallmark of modern style living in developed countries, one can expect LPR to follow.  
H. pylori, on the other hand, may or may not have the capacity to directly infect the 
respiratory mucosa. If its presence in the sinuses reflects gastric colonization, higher 
prevalence rates would be expected in the sinuses of subjects living in developing 
countries, and reports from those parts of the globe are indeed the most common. Besides 
geographic variance, the inconsistent data available also reflect the specificity and 
sensitivity of the different detection methods employed. Also, low bacterial numbers, 
unusual forms of the bacterium, and patchy and intermittent mucosal distribution are 
further confusing variables.      
This thesis investigated the hypothesis that LPR and its contents, including H. pylori, are in 
some way associated with chronic inflammatory disease of the paranasal sinuses. In a 




rhinosinusitis or concha bullosa, we assessed the specific role of individual LPR contents 
– Helicobacter pylori and pepsin – in the development of sinonasal inflammation. No 
evidence of a recent peptic reflux episode into the sinuses was found in any of the studied 
subjects, but H. pylori DNA was encountered evenly scattered through the sinuses, in 
both healthy (8% positive) and chronically inflamed mucosa (19% positive) samples, but 
this difference was not statistically significant.  
In a cohort study of patients with chronic rhinosinusitis selected for sinus surgery, we 
investigated the role of H. pylori in the pathogenesis of sinonasal inflammation, and the 
bacterium’s presence in the nose was compared to the gastric colonization pattern. We 
found that H. pylori DNA was present in the sinus mucosa of 15.4% of patients with 
chronic rhinosinusitis, all of them having concurrent H. pylori gastric infection. We also 
found that the germ’s presence in the nose was unrelated to the degree of local 
inflammation, and the bacterium could not be cultured from any of the sinus tissue 
samples.  This led us to conclude that H. pylori in the nose seems less likely a pathogen, 
but more of a tissue biomarker of reflux in the upper respiratory track.    
Considering these results, the next research project will be to investigate an eventual 
presence of H. pylori DNA in the lachrymal sac of subjects with chronic obstructive 
disease of the lachrymal drainage system undergoing endoscopic endonasal 
dacryocystorhinostomy (DCR). Documentation of the presence of the germ’s DNA in the 
lachrymal sac in a number of DCR patients would not only support a nasogenic origin for 
the obstructive disease of the lachrymal system but would also imply that reflux could 





      
 
  
   





















REFERENCES CHAPTER ONE  
1.  Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease 
(GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH 
monitoring and an experimental investigation of the role of acid and pepsin in the 
development of laryngeal injury. Laryngoscope 1991; 101 (suppl 53): 1-78.   
2. Campagnolo AM,  Priston J,  Thoen RH, Medeiros T, Assunção AR.  
Laryngopharyngeal reflux: Diagnosis, Treatment, And Latest Research. Int Arch  
Otorhinolaryngol 2014; 18: 184–191. 
3. Yılmaz T, Bajin MD, Günaydın RÖ, Ozer S, Sözen T. Laryngopharyngeal reflux and 
Helicobacter pylori. World J Gastroenterol 2014; 20: 8964-8970. 
4. Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with 
effusion in children? Laryngoscope 2002; 112: 1930-1934.  
5. Miura MS, Mascaro M, Rosenfeld RM. Association between otitis media and 
gastroesophageal reflux: a systematic review. Otolaryngol Head Neck Surg 2012; 
146:345-352. 
6. Chambers DW, Davis WE, Cook PR, et al. Long-term outcome analysis of functional 
endoscopic sinus surgery: correlation of symptoms with endoscopic examination 
findings and potential prognostic variables. Laryngoscope 1997; 107: 504–510. 
7. Bothwell MR, Parsons DS, Talbot A, et al. Outcome of reflux therapy on pediatric 
chronic sinusitis. Otolaryngol Head Neck Surg 1999; 121: 255-262.  
8. Catalano F, Terminella C, Grillo C, et al. Prevalence of oesophagitis in patients with 




9. Ulualp SO, Toohill RJ, Hoffmann R, et al. Possible relationship of gastroesophageal 
acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 1999; 13: 197-202.  
10. DiBaise JK, Olusola BF, Huerter JV, et al. Role of GERD in chronic resistant sinusitis: 
A prospective, open label, pilot trial. Am J Gastroenterol 2002; 97: 843-850.  
11. Katle EJ, Hatlebakk JG, Steinsvåg S. Gastroesophageal reflux and rhinosinusitis. Curr 
Allergy Asthma Rep 2013; 13: 218-223. 
12. Bohnhorst I, Jawad S, Lange B, et al. Prevalence of chronic rhinosinusitis in a 
population of patients with gastroesophageal reflux disease. Am J Rhinol Allergy 
2015;29: e70–e74. 
13. DeConde AS, Mace JC, Smith TL. The impact of comorbid gastroesophageal reflux 
disease on endoscopic sinus surgery quality-of-life outcomes. Int Forum Allergy 
Rhinol. 2014;4:663-669.  
14. Delehaye E, Dore MP, Bozzo C, et al. Correlation between nasal mucociliary 
clearance time and gastroesophageal reflux disease: our experience on 50 patients. 
Auris Nasus Larynx 2009;36:157-161.  
15. Durmus R, Naiboglu B, Tek A, et al. Does reflux have an effect on nasal mucociliary 
transport? Acta Oto-Laryngol 2010;130:1053-1057.  
16. DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in 
refractory chronic rhinosinusitis. Laryngoscope 2005;115: 946–957. 
17. Wong IW, Rees G, Greiff L, et al. Gastroesophageal reflux disease and chronic 





18. Wong IW, Omari TI, Myers JC, et al. Nasopharyngeal pH monitoring in chronic 
sinusitis patients using a novel four channel probe. Laryngoscope 2004; 114: 1582–
1585. 
19. Loehrl TA, Samuels TL, Poetker DM, et al. The role of extraesophageal reflux in 
medically and surgically refractory rhinosinusitis. Laryngoscope 2012;122: 1425–
1430. 
20. Ozmen S, Yucel OT, Sinici I, et al. Nasal pepsin assay and pH monitoring in chronic 
rhinosinusitis. Laryngoscope. 2008;118:890- 894. 
21. Phipps CD, Wood WE, Gibson WS, et al. Gastroesophageal reflux contributing to 
chronic sinus disease in children. A prospective analysis. Arch Otolaryngol Head 
Neck Surg 2000; 126: 831-836.    
22. Pincus RL, Kim HH, Silvers S, et al. A study of the link between gastric reflux and 
chronic sinusitis in adults. Ear Nose Throat J 2006; 85:174–178. 
23. Jecker P, Orloff LA, Wohlfeil M, et al. Gastroesophageal reflux disease (GERD), 
extraesophageal reflux (EER) and recurrent chronic rhinosinusitis. Eur Arch 
Otorhinolaryngol 2006; 263:664–667. 
24. Shaker R, Bardan E, Gu C, et al. Intrapharyngeal distribution of gastric acid refluxate. 
Laryngoscope 2003;113 :1182-1191. 
25. Wise SK, Wise JC, DelGaudio JM. Association of nasopharyngeal and 
laryngopharyngeal reflux with postnasal drip symptomatology in patients with and 
without rhinosinusitis. Am J Rhinol 2006; 20:283-289. 
26. Leason SR, Barham HP, Oakley G, et al. Association of gastro-oesophageal reflux and 




27. Unver S, Kubilay U, Sezen OS, Coskuner T. Investigation of Helicobacter pylori 
colonization in adenotonsillectomy specimens by means of the CLO test. 
Laryngoscope 2001; 111: 2183-2186. 
28. Cirak MY, Ozdek A, Yilmaz D, Bayiz U, Samim E, Turet S. Detection of 
Helicobacter pylori and its CagA gene in tonsil and adenoid tissues by PCR. Arch 
Otolaryngol Head Neck Surg 2003; 129: 1225-1229. 
29. Bulut Y, Agacayak A, Karlidag T, Toraman ZA, Yilmaz M. Association of cagA+ 
Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J Exp Med 2006; 209: 
229-233. 
30. Lin HC, Wu PY, Friedman M, Chang HW, Wilson M. Difference of Helicobacter 
pylori colonization in recurrent inflammatory and simple hyperplastic tonsil tissues. 
Arch Otolaryngol Head Neck Surg 2010; 136: 468-470. 
31. Nártová E, Kraus J, Pavlík E, Lukeš P, Katra R, Plzák J, Kolářová L, Sterzl I, Betka J, 
Astl J. Presence of different genotypes of Helicobacter pylori in patients with chronic 
tonsillitis and sleep apnoea syndrome. Eur Arch Otorhinolaryngol 2014; 271: 607-613. 
32. Pitkäranta A, Kolho KL, Rautelin H. Helicobacter pylori in children who are prone to 
upper respiratory tract infections. Arch Otolaryngol Head Neck Surg 2005; 131: 256-
258. 
33. Yilmaz M, Kara CO, Kaleli I, Demir M, Tümkaya F, Büke AS, Topuz B. Are tonsils a 
reservoir for Helicobacter pylori infection in children? Int J Pediatr Otorhinolaryngol 




34. Di Bonaventura G, Catamo G, Neri M, Neri G, Piccolomini R. Absence of 
Helicobacter pylori in tonsillar swabs from dyspeptic patients. New Microbiol 2000; 
23: 445-448. 
35. Jelavic B, Bevanda M, Ostojic M, Leventic M, Vasilj M, Knezevic E. Tonsillar 
colonization is unlikely to play important role in Helicobacter pylori infection in 
children. Int J Pediatr Otorhinolaryngol 2007;71:585-590.  
36. Katra R, Kabelka Z, Jurovcik M, Hradsky O, Kraus J, Pavlik E, Nartova E, Lukes P, 
Astl J. Pilot study: Association between Helicobacter pylori in adenoid hyperplasia 
and reflux episodes detected by multiple intraluminal impedance in children. Int J 
Pediatr Otorhinolaryngol 2014;78:1243-1249. 
37. Lukeš P, Pavlík E, Potuznikova B, Nartova E, Foltynova E, Plzak J, Katra R, Sterzl I, 
Bartunkova J, Betka J, Astl J. Detection of Helicobacter pylori in oropharyngeal 
lymphatic tissue with real-time PCR and assessment of its carcinogenic potential. Eur 
Arch Otorhinolaryngol 2014;271:399-405. 
38. Bitar MA, Soweid A, Mahfouz R, Zaatari G, Fuleihan N. Is Helicobacter pylori really 
present in the adenoids of children? Eur Arch Otorhinolaryngol 2005; 262: 987-992. 
39. Abdel-Monem MH, Magdy EA, Nour YA, Harfoush RA, Ibreak A. Detection of 
Helicobacter pylori in adenotonsillar tissue of children with chronic adenotonsillitis 
using rapid urease test, PCR and blood serology: a prospective study. Int J Pediatr 
Otorhinolaryngol 2011; 75: 568-572. 
40. Jabbari Moghaddam Y, Rafeey M, Radfar R. Comparative assessment of Helicobacter 





41. Najafipour R, Farivar TN, Pahlevan AA, Johari P, Safdarian F, Asefzadeh M. 
Agreement rate of rapid urease test, conventional PCR, and scorpion real-time PCR in 
detecting helicobacter pylori from tonsillar samples of patients with chronic 
tonsillitis.J Glob Infect Dis 2012;4:106-109.  
42. Farivar TN, Pahlevan A, Johari P, Safdarian F, Mehr MA, Najafipour R, Ahmadpour 
F. Assessment of helicobacter pylori prevalence by scorpion real-time PCR in chronic 
tonsillitis patients. J Glob Infect Dis 2012; 4: 38-42. 
43. Aliakbari I, Noohi S, Safavi SA, Tabrizi AG, Bolfion M, Razaghi M, Goudarzi H, 
Dabiri H. The role of adenotonsillar tissues as a reservoir for Helicobacter pylori and 
Helicobacter hepaticus. Gastroenterol Hepatol Bed Bench 2011; 4: 153-158. 
44. Khademi B, Niknejad N, Gandomi B, Yeganeh F. Comparison of Helicobacter pylori 
colonization on the tonsillar surface versus tonsillar core tissue as determined by the 
CLO test. Ear Nose Throat J 2007; 86: 498-501. 
45. Aslan S, Yilmaz I, Bal N, Sener M, Butros R, Demirhan B, Ozluoglu LN. 
Investigation of Helicobacter pylori in tonsillary tissue with Pronto Dry test and 
pathologic examination.Auris Nasus Larynx 2007; 34: 339-342. 
46. Skinner LJ, Winter DC, Curran AJ, Barnes C, Kennedy S, Maguire AJ, Charles DA, 
Timon CI, Burns HP. Helicobacter pylori and tonsillectomy. Clin Otolaryngol Allied 
Sci 2001; 26:505-509. 
47. Kusano K, Inokuchi A, Fujimoto K, Miyamoto H, Tokunaga O, Kuratomi Y, Shimazu 
R, Mori D, Yamasaki F, Kidera K, Tsunetomi K, Miyazaki J. Coccoid Helicobacter 





48. Minocha A, Raczkowski CA, Richards RJ. Is a history of tonsillectomy associated 
with a decreased risk of Helicobacter pylori infection? J Clin Gastroenterol 1997; 25: 
580-582. 
49. Sezen OS, Kubilay U, Erzin Y, Tuncer M, Unver S. Does tonsillectomy affect the 
outcome of drug treatment for the eradication of gastric H pylori infection? A pilot 
study. Ear Nose Throat J 2013; 92: 127-132. 
50. Pitkäranta A, Kolho KL, Rautelin H. Helicobacter pylori in children who are prone to 
upper respiratory tract infections. Arch Otolaryngol Head Neck Surg 2005; 131: 256-
258. 
51. Bitar M, Mahfouz R, Soweid A, Racoubian E, Ghasham M, Zaatari G, Fuleihan N. 
Does Helicobacter pylori colonize the nasopharynx of children and contribute to their 
middle ear disease? Acta Otolaryngol 2006; 126: 154-159. 
52. Ozcan C, Vayisoglu Y, Otag F, Polat A, Görür K, Ismi O. Does Helicobacter pylori 
have a role in the development of chronic otitis media with effusion? A preliminary 
study. J Otolaryngol Head Neck Surg 2009; 38: 526-531. 
53. Morinaka S, Tominaga M, Nakamura H. Detection of Helicobacter pylori in the 
middle ear fluid of patients with otitis media with effusion. Otolaryngol Head Neck 
Surg 2005; 133:791-794. 
54. Bai X, Wang D, Fan Z, Han Y, Xu L, Zhang G, Lu S, Liu W, Li J, Wang H. 
Helicobacter pylori may cause otitis media with effusion: a pilot study. B-ENT 2012; 




55. Karlidag T, Bulut Y, Keles E, Kaygusuz I, Yalcin S, Ozdarendeli A, Dabak H. 
Detection of Helicobacter pylori in children with otitis media with effusion: a 
preliminary report. Laryngoscope 2005; 115: 1262-1265.  
56. Fancy T, Mathers PH, Ramadan HH. Otitis media with effusion: a possible role for 
Helicobacter pylori? Otolaryngol Head Neck Surg 2009; 140: 256-258. 
57.  Park CW, Chung JH, Min HJ, Kim KR, Tae K, Cho SH, Lee SH. Helicobacter pylori 
in middle ear of children with otitis media with effusion. Chin Med J (Engl) 2011; 
124: 4275-4278. 
58. Yilmaz T, Ceylan M, Akyön Y, Ozçakýr O, Gürsel B. Helicobacter pylori: a possible 
association with otitis media with effusion. Otolaryngol Head Neck Surg 2006; 134: 
772-777. 
59. Yilmaz MD, Aktepe O, Cetinkol Y, Altuntaş A. Does Helicobacter pylori have role in 
development of otitis media with effusion? Int J Pediatr Otorhinolaryngol 2005; 69: 
745-749. 
60. Agirdir BV, Bozova S, Derin AT, Turhan M. Chronic otitis media with effusion and 
Helicobacter pylori. Int J Pediatr Otorhinolaryngol 2006; 70: 829-834. 
61. Aycicek A, Çetinkaya Z, Kıyıcı H, Bukulmez A, Yucedag F. Can Helicobacter pylori 
cause inflammation in the middle ear? Int J Pediatr Otorhinolaryngol 2012; 76: 1087-
1090.  
62. Kariya S, Okano M, Fukushima K, Nomiya S, Kataoka Y, Nomiya R, Akagi H, 
Nishizaki K. Expression of inflammatory mediators in the otitis media induced by 




63. Kutluhan A, Yurttaş V, Akarca US, Aydn A, Tuncer I, Uğraş S. Possible role of 
Helicobacter pylori in the etiopathogenesis of chronic otitis media. Otol Neurotol 
2005; 26: 1125-1127. 
64. Dagli M, Eryilmaz A, Uzun A, Kayhan B, Karabulut H. Investigation of Helicobacter 
pylori in the middle ear of the patients with chronic otitis media by CLO test and 14C 
urea breath test. Otol Neurotol 2006; 27: 871-873. 
65.  Saki N, Jahani M, Samarbaf A, Kaydani GA, Nikakhlagh S, Kenani M, Mogehi S. 
Correlation between tympanosclerosis and Helicobacter pylori. Jundishapur J 
Microbiol 2015; 8(10): e16069. 
66. Ozdek A, Cirak MY, Samim E, Bayiz U, Safak MA, Turet. S. A possible role of 
Helicobacter pylori in chronic rhinosinusitis: a preliminary report. Laryngoscope 
2003; 113: 679-682. 
67. Morinaka S, Ichimiya M, Nakamura H. Detection of Helicobacter pylori in nasal and 
maxillary sinus specimens from patients with chronic sinusitis. Laryngoscope 2003; 
113: 1557-1563. 
68. Koc C, Arikan OK, Atasoy P, Aksoy A. Prevalence of Helicobacter pylori in patients 
with nasal polyps: a preliminary report. Laryngoscope 2004; 114: 1941-1944. 
69. Cvorovic L, Brajovic D, Strbac M, Milutinovic Z, Cvorovic V.Detection of 
Helicobacter pylori in nasal polyps: preliminary report. J Otolaryngol Head Neck 
Surg 2008; 37: 192-195. 
70. Kim HY, Dhong HJ, Chung SK, Chung KW, Chung YJ, Jang KT. Intranasal 
Helicobacter pylori colonization does not correlate with the severity of chronic 




71. Ozyurt M, Gungor A, Ergunay K, Cekin E, Erkul E, Haznedaroglu T. Real-time PCR 
detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and 
laryngeal disorders. Otolaryngol Head Neck Surg 2009; 141: 131-135. 
72. Burduk PK, Kaczmarek A, Budzynska A, Kazmierczak W, Gospodarek E. Detection 
of Helicobacter pylori and cagA gene in nasal polyps and benign laryngeal diseases. 
Arch Med Res 2011; 42: 686-689. 
73. Jelavic B, Grgić M, Cupić H, Kordić M, Vasilj M, Baudoin T. Prognostic value of 
Helicobacter pylori sinonasal colonization for efficacy of endoscopic sinus surgery. 
Eur Arch Otorhinolaryngol 2012; 269: 2197-2202. 
74. Včeva A, Danić D, Včev A, Birtić D, Mihalj H, Zubčić Z, Kotromanović Z, Danić 
Hadžibegović A. The significance of Helicobacter pylori in patients with nasal 
polyposis. Med Glas (Zenica) 2012; 9: 281-286.  
75. Nemati S, Mojtahedi A, Naghavi SE, Banan R, Zia F. Investigating Helicobacter 
pylori in nasal polyposis using polymerase chain reaction, urease test and culture. Eur 
Arch Otorhinolaryngol 2012; 269: 1457-1461. 
76. Nikakhlagh S, Samarbafzadeh AR, Jahani M, Poostchi H, Kayedani GA, Naghashpoor 
M, Saki N. Determining the Role of Helicobacter pylori in Chronic Sinus Infections 
Using the Polymerase Chain Reaction. Jundishapur J Microbiol. 2015; 21;8:e20783.  
77. Cedeño EE, Ortiz-Princz D, Figueredo SA, et al. Adenoid hypertrophy and chronic 
rhinosinusitis: Helicobacter pylori on antral lavages, adenoid tissue and salival 





78. Bansal D, Sharma S, Agarwal S, Saha R,  Gupta N. Detection of Helicobacter pylori 
in Nasal Polyps. Head Neck Pathol 2016; 10:306–313. 
 
REFERENCES CHAPTER TWO  
1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease 
(GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH 
monitoring and an experimental investigation of the role of acid and pepsin in the 
development of laryngeal injury. Laryngoscope 1991; 101 (suppl 53): 1-78.   
2. Koufman JA (ed). Laryngopharyngeal reflux (LPR). Ear Nose Throat J 2002; 81 
(suppl. 2): 1-32. 
3. Contencin P, Narcy P. Nasopharyngeal pH monitoring in infants and children with 
chronic rhinopharyngitis. Int J Pediatr Otorhinolaryngol 1991; 22: 249-56. 
4. Phipps CD, Wood WE, Gibson WS, et al. Gastroesophageal reflux contributing to 
chronic sinus disease in children. A prospective analysis. Arch Otolaryngol Head 
Neck Surg 2000; 126: 831-6.    
5. DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in 
refractory chronic rhinosinusitis. Laryngoscope 2005; 115:946-57. 
6. Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with 
effusion in children? Laryngoscope 2002; 112: 1930-4.  
7. Chambers DW, Davis WE, Cook PR, et al. Long-term outcome analysis of functional 
endoscopic sinus surgery: correlation of symptoms with endoscopic examination 




8. Ulualp SO, Toohill RJ, Hoffmann R, et al. Possible relationship of gastroesophageal 
acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 1999; 13: 197-202.  
9. Loehrl TA, Smith TL, Darling RJ, et al. Autonomic dysfunction, vasomotor rhinitis, 
and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head 
Neck Surg 2002; 126: 382-7.  
10. Barbero GJ. Gastroesophageal reflux and upper airway disease. A commentary. 
Otolaryngol Clin North Am 1996; 29: 27-38.    
11. Bothwell MR, Parsons DS, Talbot A, et al. Outcome of reflux therapy on pediatric 
chronic sinusitis. Otolaryngol Head Neck Surg 1999; 121: 255-62.  
12. DiBaise JK, Olusola BF, Huerter JV, et al. Role of GERD in chronic resistant 
sinusitis: A prospective, open label, pilot trial. Am J Gastroenterol 2002; 97: 843-50.  
13. Aygenc E, Selcuk A, Celikkanat S, et al. The role of Helicobacter pylori infection in 
the cause of squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg 
2001; 125: 520-1. 
14. Morinaka S, Ichimiya M, Nakamura H. Detection of Helicobacter pylori in nasal and 
maxillary sinus specimens from patients with chronic sinusitis. Laryngoscope 2003; 
113: 1557-63. 
15. Dinis PB, Martins ML, Subtil J. Does Helicobacter pylori play a role in upper 
respiratory tract inflammation? A case report.  Ear Nose Throat J 2005; 84: 238-40. 
16. Metheny NA, Chang Y-H, Ye JS, et al. Pepsin as a marker for pulmonary aspiration. 




17. Tamura H, Tokushima H, Murakawa M, et al. Influences of Helicobacter pylori on 
serum pepsinogen concentrations in dialysis patients. Nephrol Dial Transplant 1999; 
14: 113-7.    
18. Clayton CL, Kleanthous H, Coates PJ, et al. Sensitive detection of  Helicobacter 
pylori  by using polymerase chain reaction. J Clin Microbiol 1992; 30: 192-200. 
19. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 
1175-86. 
20. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis [letter]. N Engl J Med 
2004; 351: 940-1. 
 
REFERENCES CHAPTER THREE  
1. Payão SLM, Rasmussen LT. Helicobacter pylori and its reservoirs: A correlation 
with the gastric infection. World J Gastrointest Pharmacol Ther 2016; 7: 126-132 
2. Malfertheiner MV,  Kandulski A, Schreiber J, Malfertheiner P. Helicobacter Pylori 
Infection and The Respiratory System: A Systematic Review Of The Literature. 
Digestion 2011; 84: 212-220.   
3. Ozdek A, Cirak MY, Samim E, Bayiz U, Safak MA, Turet S. A possible role of 
Helicobacter pylori in chronic rhinosinusitis: a preliminary report. Laryngoscope 
2003; 113: 679-682. 
4. Morinaka S, Ichimiya M, Nakamura H. Detection of Helicobacter pylori in nasal and 





5. Koc C, Arikan OK, Atasoy P, Aksoy A. Prevalence of Helicobacter pylori in patients 
with nasal polyps: a preliminary report. Laryngoscope 2004; 114: 1941-1944. 
6. Dinis PB, Subtil J. Helicobacter pylori and Laryngopharyngeal Reflux in Chronic 
Rhinosinusitis. Otolaryngol Head Neck Surg 2006; 134: 67-72. 
7. Cvorovic L, Brajovic D, Strbac M, Milutinovic Z, Cvorovic V. Detection of 
Helicobacter pylori in nasal polyps: preliminary report. J Otolaryngol Head Neck 
Surg 2008; 37: 192-195. 
8. Kim HY, Dhong HJ, Chung SK, Chung KW, Chung YJ, Jang KT. Intranasal 
Helicobacter pylori colonization does not correlate with the severity of chronic 
rhinosinusitis. Otolaryngol Head Neck Surg 2007; 136: 390-395. 
9. Ozyurt M, Gungor A, Ergunay K, Cekin E, Erkul E, Haznedaroglu T. Real-time PCR 
detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and 
laryngeal disorders. Otolaryngol Head Neck Surg 2009; 141: 131-135. 
10. Burduk PK, Kaczmarek A, Budzynska A, Kazmierczak W, Gospodarek E. Detection 
of Helicobacter pylori and cagA gene in nasal polyps and benign laryngeal diseases. 
Arch Med Res 2011; 42: 686-689. 
11. Jelavic B, Grgić M, Cupić H, Kordić M, Vasilj M, Baudoin T. Prognostic value of 
Helicobacter pylori sinonasal colonization for efficacy of endoscopic sinus surgery. 
Eur Arch Otorhinolaryngol 2012; 269: 2197-2202. 
12. Včeva A, Danić D, Včev A, et al. The significance of Helicobacter pylori in patients 




13. Nikakhlagh S, Samarbafzadeh AR, Jahani M, et al. Determining the Role of 
Helicobacter pylori in Chronic Sinus Infections Using the Polymerase Chain 
Reaction. Jundishapur J Microbiol 2015; 21;8:e20783.  
14. Bansal D, Sharma S, Agarwal S, Saha R, Gupta N. Detection of Helicobacter pylori 
in Nasal Polyps. Head Neck Pathol 2016; 10:306–313. 
15. Leason SR, Barham HP, Oakley G, et al. Association of gastro-oesophageal reflux 
and chronic rhinosinusitis: systematic review and meta-analysis. Rhinology 2017; 
55:3-16. 
16. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol 
Laryngol 1995; 104 (Suppl 167):17-21. 
17. Snidvongs K, Lam M, Sacks R, et al. Structured histopathology profiling of chronic 
rhinosinusitis in routine practice. Int Forum Allergy Rhinol 2012; 2:376-385. 
18. Moyaert H, Pasmans F, Ducatelle R, Haesebrouck F, Baele M.  Evaluation of 16S 
rRNA gene-based PCR assays for genus-level identification of Helicobacter species. 
J  Clin Microbiol 2008; 46: 1867–1869.  
19. Menard A, Santos A, Mégraud F, Oleastro M. PCR-Restriction Fragment Length 
Polymorphism Can Also Detect Point Mutation A2142C in the 23S rRNA Gene, 
Associated with Helicobacter pylori Resistance to Clarithromycin. Antimicrob 
Agents Chemother 2002; 46: 1156–1157. 
20. Garza-González E, Perez-Perez GI, Maldonado-Garza HJ, Bosques-Padilla FJ. A 
review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. 




21. Azevedo NF, Almeida C, Cerqueira L, Dias S, Keevil CW, Vieira MJ. Coccoid Form 
of Helicobacter pylori as a Morphological Manifestation of Cell Adaptation to the 
Environment. Appl Environ Microbiol 2007; 73: 3423–3427. 
22. Reshetnyak VI, Reshetnyak TM. Significance of dormant forms of Helicobacter 
pylori in ulcerogenesis. World J Gastroenterol 2017; 23: 4867-4878. 
23. Celli JP, Turner BS, Afdhal NH, et al.. Helicobacter pylori moves through mucus by 
reducing mucin viscoelasticity. Proc Natl Acad Sci U S A 2009; 106: 14321–14326. 
24. Ali ME-S, Pearson J P. More Than One Disease Process in Chronic Sinusitis, Based 
on Mucin Fragmentation Patterns and Amino Acid Analysis. Int J Otolaryngol 2015; 
13: 1–8. 
25. Phillipson M, Johansson MEV, Henriksnas J, et al.. The gastric mucus layers: 
constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol 















                           
APPENDIX 
 
 
86 
 
 
87 
 
 
88 
 
 
89 
 
 
90 
 
 
91 
 
 
 
 
 
 
92 
 
 
93 
 
 
94 
 
 
95 
 
 
96 
 
 
97 
 
 
98 
 
